https://www.catapult-ventures.com/ 2023-05-17T14:31:24+01:00 https://www.catapult-ventures.com/about/ 2023-05-15T13:56:44+01:00 https://www.catapult-ventures.com/team/ 2024-08-01T10:41:09+01:00 https://www.catapult-ventures.com/team/executive-team/duncan-cameron/ 2023-05-15T13:48:34+01:00 https://www.catapult-ventures.com/site/assets/files/1056/duncan_website.jpg?7jb3 https://www.catapult-ventures.com/team/executive-team/professor-rob-carroll/ 2023-05-02T22:51:54+01:00 https://www.catapult-ventures.com/site/assets/files/1057/rob_website.jpg?7kju https://www.catapult-ventures.com/team/executive-team/dr-tony-flinn/ 2023-05-02T23:00:44+01:00 https://www.catapult-ventures.com/site/assets/files/1058/tony_flinn_oct_2016_website.jpg?7kpy https://www.catapult-ventures.com/team/executive-team/kevin-dsilva/ 2023-05-02T22:57:31+01:00 https://www.catapult-ventures.com/site/assets/files/1059/kevinds_website.jpg?7kt4 https://www.catapult-ventures.com/team/executive-team/dr-gareth-king/ 2023-05-02T23:01:30+01:00 https://www.catapult-ventures.com/site/assets/files/1060/gareth_website.jpg?7l4o https://www.catapult-ventures.com/team/executive-team/laurence-vaughan/ 2023-05-02T23:02:39+01:00 https://www.catapult-ventures.com/site/assets/files/1061/laurence_website.jpg?7l6l https://www.catapult-ventures.com/team/executive-team/dr-david-whitcombe/ 2023-05-02T23:04:01+01:00 https://www.catapult-ventures.com/site/assets/files/1063/david_w_website.jpg?7l8v https://www.catapult-ventures.com/team/executive-team/nick-wright/ 2023-05-02T23:04:43+01:00 https://www.catapult-ventures.com/site/assets/files/1064/nick_website.jpg?7la1 https://www.catapult-ventures.com/team/administration-team/sarah-cooper/ 2023-05-02T23:05:45+01:00 https://www.catapult-ventures.com/site/assets/files/1065/admin_team.jpg?7lbr https://www.catapult-ventures.com/team/administration-team/anne-freeman/ 2023-05-02T23:09:19+01:00 https://www.catapult-ventures.com/site/assets/files/1066/admin_team.jpg?7lhp https://www.catapult-ventures.com/team/administration-team/corinne-lawrence/ 2023-05-02T23:10:04+01:00 https://www.catapult-ventures.com/site/assets/files/1067/admin_team.jpg?7liy https://www.catapult-ventures.com/team/administration-team/natalie-melvin/ 2023-05-02T23:10:47+01:00 https://www.catapult-ventures.com/site/assets/files/1068/admin_team.jpg?7lk5 https://www.catapult-ventures.com/team/advisors/hamish-graham/ 2023-05-02T23:11:43+01:00 https://www.catapult-ventures.com/site/assets/files/1069/hamish_website.jpg?7llp https://www.catapult-ventures.com/portfolio/ 2024-10-29T14:01:26+00:00 https://www.catapult-ventures.com/portfolio/4energy-limited/ 2023-05-23T12:01:12+01:00 https://www.catapult-ventures.com/site/assets/files/1130/4-energylogo.jpg?91ql https://www.catapult-ventures.com/portfolio/abzena-plc/ 2023-05-11T21:39:14+01:00 https://www.catapult-ventures.com/site/assets/files/1132/abzena_logo_rgb72dpi.jpg?91sj https://www.catapult-ventures.com/portfolio/accutronics-limited/ 2023-05-23T12:12:25+01:00 https://www.catapult-ventures.com/site/assets/files/1133/accutronics_logo_final_300dpi_jpg.jpg?91u9 https://www.catapult-ventures.com/portfolio/acea-health-flynotes/ 2023-05-24T12:16:35+01:00 https://www.catapult-ventures.com/site/assets/files/1077/631_acea_flynotes_2020_logo.png?7orz https://www.catapult-ventures.com/portfolio/apex-molecular/ 2023-05-03T17:07:53+01:00 https://www.catapult-ventures.com/site/assets/files/1078/apex_master.jpg?8z6e https://www.catapult-ventures.com/portfolio/arlabion/ 2023-05-24T12:22:48+01:00 https://www.catapult-ventures.com/site/assets/files/1084/arlabion_logo.jpg?8zhe https://www.catapult-ventures.com/portfolio/atlantic-link-limited/ 2023-05-16T12:22:48+01:00 https://www.catapult-ventures.com/site/assets/files/1136/atlanticlink_sm.jpg?91wb https://www.catapult-ventures.com/portfolio/biofortuna-limited/ 2025-12-09T15:01:47+00:00 https://www.catapult-ventures.com/site/assets/files/1087/biofortuna-logo-2018-rgb.jpg?8zuf https://www.catapult-ventures.com/portfolio/biohabit/ 2023-05-03T17:20:10+01:00 https://www.catapult-ventures.com/site/assets/files/1090/biohabit_logo.jpg?8zzs https://www.catapult-ventures.com/portfolio/biorelate/ 2023-05-24T12:58:53+01:00 https://www.catapult-ventures.com/site/assets/files/1092/biorelate_new_2020.png?9013 https://www.catapult-ventures.com/portfolio/bitrobius-genetics/ 2023-05-03T17:29:24+01:00 https://www.catapult-ventures.com/site/assets/files/1093/bitrobius_compact_logo.jpg?90f6 https://www.catapult-ventures.com/portfolio/blackstar-amplification-limited/ 2023-05-23T12:13:31+01:00 https://www.catapult-ventures.com/site/assets/files/1138/blackstar-logo.jpg?91xl https://www.catapult-ventures.com/portfolio/blueberry-therapeutics/ 2023-05-03T17:30:00+01:00 https://www.catapult-ventures.com/site/assets/files/1094/blueberry_therapeutics_logo_rgb.jpg?90g6 https://www.catapult-ventures.com/portfolio/brainberry-formerly-cerebrum-matter/ 2024-08-14T12:16:44+01:00 https://www.catapult-ventures.com/site/assets/files/1095/cerebrum_logo.jpg?90l6 https://www.catapult-ventures.com/portfolio/bsolve-dental-limited/ 2023-05-23T12:07:11+01:00 https://www.catapult-ventures.com/site/assets/files/1096/bsolvedental_white_rgb_artwork.png?90n5 https://www.catapult-ventures.com/portfolio/bwb-consulting-limited/ 2024-08-14T11:44:41+01:00 https://www.catapult-ventures.com/site/assets/files/1139/bwbweb.jpeg?91zd https://www.catapult-ventures.com/portfolio/cancertain/ 2023-05-03T17:34:48+01:00 https://www.catapult-ventures.com/site/assets/files/1097/cancertain.jpg?90o6 https://www.catapult-ventures.com/portfolio/clin-e-cal/ 2023-05-03T17:35:21+01:00 https://www.catapult-ventures.com/site/assets/files/1098/clinecal_logo.png?90p3 https://www.catapult-ventures.com/portfolio/crobio/ 2025-02-12T12:26:16+00:00 https://www.catapult-ventures.com/site/assets/files/1099/crobio_logo_dark.svg?xq95y https://www.catapult-ventures.com/portfolio/crystallon-limited/ 2024-08-14T11:46:10+01:00 https://www.catapult-ventures.com/site/assets/files/1141/oxcryologocolour.jpg?920s https://www.catapult-ventures.com/portfolio/cyclops-limited/ 2024-10-29T14:07:07+00:00 https://www.catapult-ventures.com/site/assets/files/1100/cyclops_logo_2021.jpg?90tj https://www.catapult-ventures.com/portfolio/cytox/ 2024-05-01T11:41:07+01:00 https://www.catapult-ventures.com/site/assets/files/1644/cytox_logo.jpeg?o5n1 https://www.catapult-ventures.com/portfolio/de-pack-limited/ 2023-05-23T12:16:34+01:00 https://www.catapult-ventures.com/site/assets/files/1145/depack_logo_hi_res.jpeg?924t https://www.catapult-ventures.com/portfolio/food-and-drug-analytical-services-limited/ 2023-05-11T21:40:09+01:00 https://www.catapult-ventures.com/site/assets/files/1147/fdas_logo_cmyk_converted.jpg?925v https://www.catapult-ventures.com/portfolio/gendius/ 2025-04-29T15:05:00+01:00 https://www.catapult-ventures.com/site/assets/files/1645/gendius-logo-horizontal-large-dark_2x-100.jpg?o5op https://www.catapult-ventures.com/portfolio/haemostatix/ 2023-05-11T21:40:24+01:00 https://www.catapult-ventures.com/site/assets/files/1148/haemostatix_logo_for_website.jpg?927s https://www.catapult-ventures.com/portfolio/hangar-seven-limited/ 2023-05-16T12:23:19+01:00 https://www.catapult-ventures.com/site/assets/files/1149/h7_logo_cool_grey-black.jpg?928z https://www.catapult-ventures.com/portfolio/healum/ 2023-05-24T12:43:52+01:00 https://www.catapult-ventures.com/site/assets/files/1646/healum.png?o5r8 https://www.catapult-ventures.com/portfolio/infex-therapeutics/ 2023-05-03T17:38:33+01:00 https://www.catapult-ventures.com/site/assets/files/1103/infex_logo.png?90uf https://www.catapult-ventures.com/portfolio/kick-sport-limited/ 2023-05-23T12:08:07+01:00 https://www.catapult-ventures.com/site/assets/files/1104/kick_sport.jpg?90ve https://www.catapult-ventures.com/portfolio/lifeskills-education-holdings-limited/ 2023-05-03T18:09:29+01:00 https://www.catapult-ventures.com/site/assets/files/1151/sc_logo_notext_-_pos_cmyk_hr.jpg?929z https://www.catapult-ventures.com/portfolio/lumora-limited/ 2023-05-16T12:23:52+01:00 https://www.catapult-ventures.com/site/assets/files/1152/lumora-final-logo-blend2.jpeg?92b4 https://www.catapult-ventures.com/portfolio/manchester-biotech-manchester-biogel/ 2023-05-24T12:25:39+01:00 https://www.catapult-ventures.com/site/assets/files/1106/manchester_biogel_logo_wht_rgb.jpg?90we https://www.catapult-ventures.com/portfolio/manchester-imaging/ 2023-05-24T12:44:15+01:00 https://www.catapult-ventures.com/site/assets/files/1647/manchester_imaging_logo.jpg?o5tf https://www.catapult-ventures.com/portfolio/maxwellia/ 2023-05-24T12:44:52+01:00 https://www.catapult-ventures.com/site/assets/files/1648/maxwellia_logotype_and_strapline_2018_1.png?o5uq https://www.catapult-ventures.com/portfolio/metalinear/ 2023-05-16T12:43:05+01:00 https://www.catapult-ventures.com/site/assets/files/1107/metalinear_logo.jpg?90xf https://www.catapult-ventures.com/portfolio/microbiosensor/ 2023-05-24T13:00:06+01:00 https://www.catapult-ventures.com/site/assets/files/1649/microbiosensor_nostrap_cmyk.jpg?o5vw https://www.catapult-ventures.com/portfolio/monica-healthcare-limited/ 2026-03-17T12:02:30+00:00 https://www.catapult-ventures.com/site/assets/files/1153/monica_logo_hi_res.jpg?92c6 https://www.catapult-ventures.com/portfolio/monument-therapeutics/ 2023-05-24T13:00:44+01:00 https://www.catapult-ventures.com/site/assets/files/1108/monument_tx_logo.jpg?90zu https://www.catapult-ventures.com/portfolio/myhelp/ 2023-05-03T17:42:22+01:00 https://www.catapult-ventures.com/site/assets/files/1110/my_help.png?910s https://www.catapult-ventures.com/portfolio/nexus-labs/ 2025-04-29T15:00:42+01:00 https://www.catapult-ventures.com/site/assets/files/1111/nexus_labs_cropped.jpg?911x https://www.catapult-ventures.com/portfolio/oracle-care-limited/ 2023-05-16T12:24:15+01:00 https://www.catapult-ventures.com/site/assets/files/1154/oracle_care.jpg?92ea https://www.catapult-ventures.com/portfolio/ovo-biomanufacturing/ 2023-05-03T17:44:50+01:00 https://www.catapult-ventures.com/site/assets/files/1113/ovo_bio_dec_2020.png?914w https://www.catapult-ventures.com/portfolio/oxford-biotherapeutics-limited/ 2023-05-23T12:08:32+01:00 https://www.catapult-ventures.com/site/assets/files/1114/obt-rgb_500_192.jpg?915u https://www.catapult-ventures.com/portfolio/panthera-biopartners/ 2023-05-03T18:12:52+01:00 https://www.catapult-ventures.com/site/assets/files/1155/panthera-corporate-black_on_white.png?92fm https://www.catapult-ventures.com/portfolio/pebble-biotechnology-laboratories/ 2023-05-03T17:45:54+01:00 https://www.catapult-ventures.com/site/assets/files/1115/pebble_bio_logo.jpg?916o https://www.catapult-ventures.com/portfolio/pencil-biosciences/ 2025-09-16T11:45:10+01:00 https://www.catapult-ventures.com/site/assets/files/1116/pencil_logo_main_colour_rgb.svg?18u4hg https://www.catapult-ventures.com/portfolio/pill-connect/ 2023-05-03T17:47:02+01:00 https://www.catapult-ventures.com/site/assets/files/1117/702_pill-connect-logo-full-colour-rgb-1000px_72ppi.png?918k https://www.catapult-ventures.com/portfolio/pronec/ 2023-05-03T17:47:32+01:00 https://www.catapult-ventures.com/site/assets/files/1118/pronec.jpg?919e https://www.catapult-ventures.com/portfolio/proveca/ 2023-05-24T13:12:28+01:00 https://www.catapult-ventures.com/site/assets/files/1119/proveca_logo.jpg?91a7 https://www.catapult-ventures.com/portfolio/qv-bioelectronics/ 2023-05-03T17:48:42+01:00 https://www.catapult-ventures.com/site/assets/files/1120/qvb_1500px_579px.png?91bc https://www.catapult-ventures.com/portfolio/r2c-online-limited/ 2024-08-14T11:46:54+01:00 https://www.catapult-ventures.com/site/assets/files/1158/r2c.jpeg?92i3 https://www.catapult-ventures.com/portfolio/r5-pharmaceuticals-limited/ 2023-05-16T12:25:05+01:00 https://www.catapult-ventures.com/site/assets/files/1159/logo_r5_pharmal.jpg?92j3 https://www.catapult-ventures.com/portfolio/renephra/ 2023-05-24T12:49:55+01:00 https://www.catapult-ventures.com/site/assets/files/1650/renephra_logo.jpg?o5xr https://www.catapult-ventures.com/portfolio/rinicare/ 2024-05-01T11:42:03+01:00 https://www.catapult-ventures.com/site/assets/files/1121/rinicare_logo_standard.jpg?91d5 https://www.catapult-ventures.com/portfolio/sight-and-sound-limited/ 2023-05-23T14:07:35+01:00 https://www.catapult-ventures.com/site/assets/files/1656/new_logo_full_colour.jpg?19s20 https://www.catapult-ventures.com/portfolio/silver-lining-solutions-limited/ 2023-05-16T12:25:31+01:00 https://www.catapult-ventures.com/site/assets/files/1160/355_silverliningsolutions.jpg?92mi https://www.catapult-ventures.com/portfolio/swabtech/ 2023-05-24T12:36:03+01:00 https://www.catapult-ventures.com/site/assets/files/1122/swabtech_logo_final.jpg?91e2 https://www.catapult-ventures.com/portfolio/systems-integration-trading-limited/ 2023-05-16T12:26:27+01:00 https://www.catapult-ventures.com/site/assets/files/1161/system_integration_logo.jpg?92nt https://www.catapult-ventures.com/portfolio/tectores/ 2023-05-03T17:56:04+01:00 https://www.catapult-ventures.com/site/assets/files/1123/tectores_pellitec-logo.png?91fc https://www.catapult-ventures.com/portfolio/trio-healthcare/ 2024-01-17T11:26:24+00:00 https://www.catapult-ventures.com/site/assets/files/1124/trio-logo.jpg?91ij https://www.catapult-ventures.com/portfolio/turbine-efficiency-limited/ 2023-05-23T12:28:33+01:00 https://www.catapult-ventures.com/site/assets/files/1162/883_turbine.jpg?92ot https://www.catapult-ventures.com/portfolio/virustatic/ 2023-05-03T18:19:18+01:00 https://www.catapult-ventures.com/site/assets/files/1163/virustatic_shield.jpg?92pw https://www.catapult-ventures.com/portfolio/viscgo/ 2023-05-03T17:53:36+01:00 https://www.catapult-ventures.com/site/assets/files/1126/viscgo-logo-220x71.jpg?91ji https://www.catapult-ventures.com/portfolio/whelan-refining-limited/ 2023-05-23T12:29:09+01:00 https://www.catapult-ventures.com/site/assets/files/1164/whelanlogo.jpg?92r4 https://www.catapult-ventures.com/portfolio/yospace-limited/ 2024-08-14T11:48:32+01:00 https://www.catapult-ventures.com/site/assets/files/1165/yospace_pink.jpeg?92s6 https://www.catapult-ventures.com/portfolio/yourmedpack/ 2023-05-24T13:06:14+01:00 https://www.catapult-ventures.com/site/assets/files/1127/yourmedpack_logo.png?91lf https://www.catapult-ventures.com/funds/ 2023-05-03T20:27:38+01:00 https://www.catapult-ventures.com/news/ 2023-04-28T21:13:23+01:00 https://www.catapult-ventures.com/news/oxford-biotherapeutics-enters-strategic-collaboration-with-bristol-myers-squibb-to-discover-and-develop-next-generation-t-cell/ 2026-04-14T10:06:47+01:00 https://www.catapult-ventures.com/site/assets/files/1743/obt-rgb_250_96.jpg?1jmvvf https://www.catapult-ventures.com/news/european-medicines-agency-adopts-positive-opinion-for-bopediat-furosemide-as-provecas-third-paediatric-use-marketing/ 2026-04-13T10:50:41+01:00 https://www.catapult-ventures.com/site/assets/files/1742/proveca_logo_outlined.jpg?1jl3an https://www.catapult-ventures.com/news/proveca-submits-a-new-drug-application-to-the-u.s-food-and-drug-administration/ 2026-03-25T10:10:31+00:00 https://www.catapult-ventures.com/site/assets/files/1741/proveca_logo_outlined.jpg?1ilxfe https://www.catapult-ventures.com/news/proveca-and-bcworld-healthcare-announce-the-launch-of-the-first-licensed-product-in-south-korea/ 2026-03-23T10:54:16+00:00 https://www.catapult-ventures.com/site/assets/files/1740/proveca_logo_outlined.jpg?1iia8m https://www.catapult-ventures.com/news/monument-therapeutics-announces-first-patient-dosed-in-clinical-trial-of-mt1988-in-patients-at-clinical-high-risk-for-psychosis/ 2026-03-10T11:55:46+00:00 https://www.catapult-ventures.com/site/assets/files/1739/monument_tx_logo.jpg?1huaf4 https://www.catapult-ventures.com/news/biofortuna-pioneers-new-robotic-system-for-diagnostic-tests/ 2026-02-23T12:50:49+00:00 https://www.catapult-ventures.com/site/assets/files/1738/biofortuna-logo-2018-rgb.jpg?1h2kyv https://www.catapult-ventures.com/news/proveca-announces-exclusive-worldwide-development-and-license-agreement-with-catalent-for-its-zydis-odt-technology-for-use-with/ 2026-02-11T12:08:42+00:00 https://www.catapult-ventures.com/site/assets/files/1737/proveca_logo_outlined.jpg?1ggaw4 https://www.catapult-ventures.com/news/qv-bioelectronics-receives-4.5m-boost-for-implantable-brain-cancer-therapy/ 2026-01-21T10:00:29+00:00 https://www.catapult-ventures.com/site/assets/files/1736/logo.png?1fd92z https://www.catapult-ventures.com/news/oxford-biotherapeutics-enters-into-strategic-collaboration-with-gsk-to-discover-novel-targets-for-antibody-based-therapeutics/ 2025-12-10T12:04:54+00:00 https://www.catapult-ventures.com/site/assets/files/1735/obt-rgb_1417_544.jpg?1d7mp7 https://www.catapult-ventures.com/news/welsh-government-ministers-visit-biofortuna-to-celebrate-innovation-and-skills-development/ 2025-12-09T14:58:46+00:00 https://www.catapult-ventures.com/site/assets/files/1734/biofortuna_visit.jpg?1d6084 https://www.catapult-ventures.com/news/maxwellia-pharmacist-and-otc-innovator-named-north-west-innovation-entrepreneur-of-the-year/ 2025-11-24T11:07:11+00:00 https://www.catapult-ventures.com/site/assets/files/1732/anna-maxwell-maxwellia.jpg?1cdxcf https://www.catapult-ventures.com/news/new-prescription-strength-pain-relief-hits-high-street-chemists-hailed-as-game-changer-by-pharmacists/ 2025-10-13T13:14:45+01:00 https://www.catapult-ventures.com/site/assets/files/1731/maxwellia_logotype_and_strapline_cmyk_2018.jpg?1a88hk https://www.catapult-ventures.com/news/pencil-biosciences-appoints-jonathan-thon-phd-as-chair-of-the-board-of-directors/ 2025-09-16T11:43:21+01:00 https://www.catapult-ventures.com/site/assets/files/1730/pencil_logo_main_colour_rgb-1.svg?18u4c0 https://www.catapult-ventures.com/news/the-biorenewables-development-centre-partners-with-crobio-on-engineering-biology-award-to-tackle-water-scarcity/ 2025-09-15T11:05:56+01:00 https://www.catapult-ventures.com/site/assets/files/1729/crobio_logo_dark.svg?18s802 https://www.catapult-ventures.com/news/aardex-group-and-pill-connect-partner-to-advance-dose-selection-with-real-time-adherence-monitoring-in-phase-2a-clinical-trial/ 2025-08-27T12:18:54+01:00 https://www.catapult-ventures.com/site/assets/files/1728/pill-connect-logo-full-colour-rgb-1000px_72ppi.png?17t4po https://www.catapult-ventures.com/news/monument-therapeutics-announces-partnership-with-foundation-for-the-national-institutes-of-health-for-clinical-trial-of-mt1988/ 2025-08-20T10:27:40+01:00 https://www.catapult-ventures.com/site/assets/files/1727/monument_tx_logo.jpg?17g0wa https://www.catapult-ventures.com/news/marketing-authorisation-application-for-ct001-submitted-to-the-european-medicines-agency-for-acute-pain-management-in-children/ 2025-08-19T10:32:05+01:00 https://www.catapult-ventures.com/site/assets/files/1726/proveca_logo_outlined.jpg?17e6fn https://www.catapult-ventures.com/news/maxwellia-announces-three-new-board-appointments-to-strengthen-commercial-and-strategic-leadership/ 2025-07-29T12:18:49+01:00 https://www.catapult-ventures.com/site/assets/files/1725/maxwellia_board_appointments_july_25.jpg?16bf42 https://www.catapult-ventures.com/news/oxford-biotherapeutics-announces-third-oncology-drug-candidate-from-boehringer-ingelheim-collaboration-selected-to-advance-into/ 2025-07-07T11:00:29+01:00 https://www.catapult-ventures.com/site/assets/files/1724/obt-rgb_400_154.jpg?156l00 https://www.catapult-ventures.com/news/monument-therapeutics-reports-positive-phase-i-results-for-novel-cognitive-impairment-in-schizophrenia-treatment/ 2025-06-23T12:45:42+01:00 https://www.catapult-ventures.com/site/assets/files/1723/monument_tx_logo.jpg?14gsma https://www.catapult-ventures.com/news/infex-therapeutics-agrees-collaboration-with-asian-clinical-trials-network-advance-id/ 2025-05-21T11:14:54+01:00 https://www.catapult-ventures.com/site/assets/files/1721/infex_logo_white_text.png?12rkf0 https://www.catapult-ventures.com/news/qv-bioelectronics-awarded-1.26m-to-advance-studies-on-new-brain-cancer-treatment/ 2025-05-07T10:35:25+01:00 https://www.catapult-ventures.com/site/assets/files/1720/qvb_1500px_927px.png?121l32 https://www.catapult-ventures.com/news/monument-therapeutics-announces-appointment-of-robert-radie-as-chair-and-heather-preston-to-advisory-board/ 2025-04-28T12:23:45+01:00 https://www.catapult-ventures.com/site/assets/files/1719/monument_tx_logo.jpg?11l29r https://www.catapult-ventures.com/news/maxwellia-appoints-alexandra-trehane-as-chief-operating-officer-as-company-sets-to-scale/ 2025-04-09T11:47:00+01:00 https://www.catapult-ventures.com/site/assets/files/1718/maxwellia_alexandra_trehane.jpg?10ltwi https://www.catapult-ventures.com/news/oxford-biotherapeutics-enters-into-a-strategic-collaboration-with-roche-to-discover-novel-targets-for-antibody-based/ 2025-03-24T09:48:12+00:00 https://www.catapult-ventures.com/site/assets/files/1717/obt-rgb_1417_544.jpg?zs4h8 https://www.catapult-ventures.com/news/gm-c-life-sciences-fund-announces-100m-in-matched-private-sector-investment-for-greater-manchester-cheshire-and-warrington/ 2025-03-24T10:36:20+00:00 https://www.catapult-ventures.com/site/assets/files/1716/catapult_ventures_cymk_hres_med_for_publications_290_high.jpg?zkp0r https://www.catapult-ventures.com/news/monument-therapeutics-secures-850k-to-advance-breakthrough-schizophrenia-treatment/ 2025-02-26T10:34:08+00:00 https://www.catapult-ventures.com/site/assets/files/1715/monument_tx_logo.jpg?yg19o https://www.catapult-ventures.com/news/infex-signs-exclusive-license-agreement-with-venus-remedies-ltd-to-advance-met-x-through-clinical-development-and/ 2025-02-25T10:25:26+00:00 https://www.catapult-ventures.com/site/assets/files/1714/infex_logo.png?ye68k https://www.catapult-ventures.com/news/infex-and-justus-liebig-university-giessen-awarded-1-million-grant-from-pace/ 2025-02-18T11:19:43+00:00 https://www.catapult-ventures.com/site/assets/files/1713/infex_logo_white_text.png?y1a2i https://www.catapult-ventures.com/news/manchester-medtech-company-pill-connect-secures-new-investment-to-transform-clinical-trials/ 2025-02-17T11:59:31+00:00 https://www.catapult-ventures.com/site/assets/files/1712/img_7522.jpeg?xzh8l https://www.catapult-ventures.com/news/agtech-startup-crobio-raises-850k-to-reshape-agriculture-through-enhanced-microbes/ 2025-02-12T12:22:48+00:00 https://www.catapult-ventures.com/site/assets/files/1711/crobio_logo_dark.svg?xq8ws https://www.catapult-ventures.com/news/monument-therapeutics-announces-grant-of-chinese-patent-in-support-of-its-mt1988-cognitive-impairment-associated-with/ 2025-01-21T13:48:31+00:00 https://www.catapult-ventures.com/site/assets/files/1709/monument_tx_logo.jpg?wlmb1 https://www.catapult-ventures.com/news/monument-therapeutics-announces-grant-of-japanese-patent-in-support-of-its-mt1988-cognitive-impairment-associated-with/ 2025-01-14T10:54:29+00:00 https://www.catapult-ventures.com/site/assets/files/1708/monument_tx_logo.jpg?w8fkz https://www.catapult-ventures.com/news/boehringer-ingelheim-acquires-fourth-license-for-the-development-of-novel-antibody-based-cancer-treatments-from-oxford/ 2025-01-13T12:30:48+00:00 https://www.catapult-ventures.com/site/assets/files/1707/obt-rgb_1417_544.jpg?w6pdi https://www.catapult-ventures.com/news/maxwellia-announces-strategic-leadership-appointments-to-propel-future-growth/ 2025-01-09T13:55:03+00:00 https://www.catapult-ventures.com/site/assets/files/1706/maxwellia_hires.png?vzelx https://www.catapult-ventures.com/news/maxwellia-launches-unexpected-menstrual-health-campaign-following-concerning-survey-results/ 2024-11-27T11:25:35+00:00 https://www.catapult-ventures.com/site/assets/files/1705/maxwellia_logotype_and_strapline_cmyk_2018.jpg?trkyr https://www.catapult-ventures.com/news/monument-therapeutics-launches-first-clinical-study-of-mt1988-a-novel-treatment-for-cognitive-impairment-associated-with/ 2024-11-26T11:15:17+00:00 https://www.catapult-ventures.com/site/assets/files/1704/monument_tx_logo.jpg?tppvn https://www.catapult-ventures.com/news/monument-therapeutics-announces-appointment-of-dr-stephen-brannan-dr-jeff-baker-and-dr-mark-treherne-to-its-advisory-board-to/ 2024-11-19T11:30:35+00:00 https://www.catapult-ventures.com/site/assets/files/1703/monument_tx_logo.jpg?tcrx5 https://www.catapult-ventures.com/news/apex-molecular-ltd-appoints-dr-jason-tierney-as-a-medicinal-chemistry-consultant/ 2024-11-07T10:26:59+00:00 https://www.catapult-ventures.com/site/assets/files/1702/apex_master.jpg?sqgwe https://www.catapult-ventures.com/news/monument-therapeutics-secures-1m-investment-to-fund-its-schizophrenia-programme-and-drive-next-stage-of-growth/ 2024-10-15T10:11:36+01:00 https://www.catapult-ventures.com/site/assets/files/1700/monument_tx_logo.jpg?rjs4x https://www.catapult-ventures.com/news/lyva-labs-invests-50-000-into-health-innovators-tectores/ 2024-09-25T14:58:52+01:00 https://www.catapult-ventures.com/site/assets/files/1699/tectores_pellitec-logo.png?qj44a https://www.catapult-ventures.com/news/monument-therapeutics-announces-grant-of-uk-patent-for-neuroinflammation-compound-mt1980/ 2024-09-18T12:00:15+01:00 https://www.catapult-ventures.com/site/assets/files/1698/monument_tx_logo.jpg?q5x6l https://www.catapult-ventures.com/news/first-ncfb-patient-dosed-in-resp-x-phase-iia-study/ 2024-09-17T11:11:37+01:00 https://www.catapult-ventures.com/site/assets/files/1697/infex_logo.png?q409j https://www.catapult-ventures.com/news/qv-bioelectronics-delivers-breakthrough-pre-clinical-safety-and-efficacy-results-for-electric-field-therapy-in-the-treatment-of/ 2024-09-10T14:03:30+01:00 https://www.catapult-ventures.com/site/assets/files/1696/logo.png?pr9hm https://www.catapult-ventures.com/news/respected-pharma-data-science-pioneer-dr-ben-sidders-to-spearhead-biorelates-next-growth-phase-as-chief-scientific-officer/ 2024-09-06T10:35:33+01:00 https://www.catapult-ventures.com/site/assets/files/1695/biorelate_new_2020.png?pjl5o https://www.catapult-ventures.com/news/qv-bioelectronics-secures-343-000-from-innovate-uks-cancer-therapeutics-programme-to-develop-a-new-treatment-for-childhood/ 2024-09-05T11:57:38+01:00 https://www.catapult-ventures.com/site/assets/files/1694/qvb_1500px_579px.png?phudp https://www.catapult-ventures.com/news/infex-therapeutics-to-present-resp-x-phase-i-data-at-ers-congress/ 2024-09-03T13:55:08+01:00 https://www.catapult-ventures.com/site/assets/files/1693/infex_logo_white_text.png?peai2 https://www.catapult-ventures.com/news/cessatech-and-proveca-announce-world-wide-excluding-us-commercial-partnership-for-ct001/ 2024-10-16T10:10:02+01:00 https://www.catapult-ventures.com/site/assets/files/1701/proveca_logo.png?rlmqw https://www.catapult-ventures.com/news/oxford-biotherapeutics-named-best-tech-sme-of-the-year-at-thames-valley-tech-innovation-awards-2024/ 2024-07-22T14:57:12+01:00 https://www.catapult-ventures.com/site/assets/files/1692/obt-rgb_500_192.jpg?n6qpi https://www.catapult-ventures.com/news/wirral-footcare-manufacturer-tectores-steps-into-india/ 2024-06-20T13:42:04+01:00 https://www.catapult-ventures.com/site/assets/files/1691/tectores_pellitec-logo.png?ljdwa https://www.catapult-ventures.com/news/infex-therapeutics-strengthens-its-senior-leadership-team/ 2024-05-20T13:47:13+01:00 https://www.catapult-ventures.com/site/assets/files/1690/infex_logo.png?jxzgv https://www.catapult-ventures.com/news/biofortuna-completes-acquisition-of-biological-sample-storage-experts-cryoniss/ 2024-05-09T12:56:42+01:00 https://www.catapult-ventures.com/site/assets/files/1689/biofortuna-logo-2018-rgb.jpg?jdjso https://www.catapult-ventures.com/news/crobio-announces-completion-of-1.55-million-seed-round/ 2024-04-24T11:19:01+01:00 https://www.catapult-ventures.com/site/assets/files/1688/crobio.jpg?iln5d https://www.catapult-ventures.com/news/precision-neuroscience-company-monument-therapeutics-announces-1.5m-funding-to-kickstart-schizophrenia-clinical-development/ 2024-04-22T10:12:23+01:00 https://www.catapult-ventures.com/site/assets/files/1687/monument_tx_logo.jpg?ihuut https://www.catapult-ventures.com/news/maxwellia-revolutionises-menstrual-health-category-in-pharmacy-with-the-introduction-of-evana-and-ultravana/ 2024-04-09T12:02:06+01:00 https://www.catapult-ventures.com/site/assets/files/1686/maxwellia_logotype_and_strapline_2018_1.png?htvzs https://www.catapult-ventures.com/news/sight-and-sound-announces-partnership-with-speaksee/ 2024-03-20T14:33:06+00:00 https://www.catapult-ventures.com/site/assets/files/1685/new_logo_full_colour.jpg?gt5pc https://www.catapult-ventures.com/news/oxford-biotherapeutics-announces-launch-of-enhanced-discovery-platform-ogap-verify-at-world-adc-conference-2024/ 2024-03-07T10:57:02+00:00 https://www.catapult-ventures.com/site/assets/files/1684/obt-rgb_500_192.jpg?g4t18 https://www.catapult-ventures.com/news/pill-connect-announces-its-acceptance-onto-the-leading-cdmos-smart-packaging-supply-program/ 2024-03-05T14:40:31+00:00 https://www.catapult-ventures.com/site/assets/files/1683/pill-connect-logo-full-colour-rgb-1000px_72ppi.png?g1e1p https://www.catapult-ventures.com/news/maxwellia-announces-the-launch-of-lovitest/ 2024-02-21T13:03:36+00:00 https://www.catapult-ventures.com/site/assets/files/1682/maxwellia_logotype_and_strapline_cmyk_2018.jpg?fd6su https://www.catapult-ventures.com/news/lovione-crowned-winner-of-the-pharmacy-product-of-the-year-consumers-choice-2024/ 2024-02-20T12:09:30+00:00 https://www.catapult-ventures.com/site/assets/files/1680/maxwellia_logotype_and_strapline_cmyk_2018.jpg?fb9q0 https://www.catapult-ventures.com/news/innovation-funding-boost-for-blister-prevention-firm/ 2024-02-14T13:06:31+00:00 https://www.catapult-ventures.com/site/assets/files/1679/tectores_pellitec-logo.png?f08d1 https://www.catapult-ventures.com/news/oxford-biotherapeutics-announces-first-patient-dosed-with-lead-candidate-obt076-in-phase-1b-trial-in-adenoid-cystic-carcinomas/ 2024-01-18T14:51:06+00:00 https://www.catapult-ventures.com/site/assets/files/1678/obt-rgb_500_192.jpg?dmd6l https://www.catapult-ventures.com/news/monument-therapeutics-announces-the-grant-of-u.s-patent-supporting-mt1988-program-for-schizophrenia/ 2024-01-08T12:52:34+00:00 https://www.catapult-ventures.com/site/assets/files/1677/monument_tx_logo.jpg?d3oys https://www.catapult-ventures.com/news/oxford-biotherapeutics-announces-partner-boehringer-ingelheim-received-u.s-fda-fast-track-designation-for-bi-764532-for/ 2023-11-30T10:40:37+00:00 https://www.catapult-ventures.com/site/assets/files/1676/obt-rgb_500_192.jpg?b3axv https://www.catapult-ventures.com/news/blueberry-therapeutics-meets-primary-and-secondary-endpoints-in-phase-2b-trial-in-onychomycosis/ 2023-11-13T12:45:49+00:00 https://www.catapult-ventures.com/site/assets/files/1675/blueberry_therapeutics_logo_rgb.jpg?a7zej https://www.catapult-ventures.com/news/infex-therapeutics-resp-x-successfully-completes-phase-i-trial-and-initiates-phase-iia-trial-in-ncfb-patients/ 2023-11-03T09:31:50+00:00 https://www.catapult-ventures.com/site/assets/files/1674/infex_logo_white_text.png?9p7r8 https://www.catapult-ventures.com/news/oxford-biotherapeutics-announces-partner-boehringer-ingelheim-dosed-first-patient-in-phase-2-trial-with-bi-764532-in-small-cell/ 2023-10-25T12:07:49+01:00 https://www.catapult-ventures.com/site/assets/files/1673/obt-rgb_400_154.jpg?98o3g https://www.catapult-ventures.com/news/qv-bioelectronics-and-incubate-bio-announce-successful-outcome-of-strategic-collaboration-to-accelerate-new-treatment-option/ 2023-10-24T10:19:08+01:00 https://www.catapult-ventures.com/site/assets/files/1672/logo.png?96oi2 https://www.catapult-ventures.com/news/oxford-biotherapeutics-relocates-uk-headquarters-to-strategic-and-cutting-edge-r-d-location-at-the-oxford-science-park/ 2023-10-11T12:37:35+01:00 https://www.catapult-ventures.com/site/assets/files/1671/obt-rgb_500_192.jpg?8is8t https://www.catapult-ventures.com/news/fast-track-designation-granted-to-bi-764532-for-the-treatment-of-extensive-stage-small-cell-lung-cancer/ 2023-10-05T13:15:38+01:00 https://www.catapult-ventures.com/site/assets/files/1670/obt-rgb_400_154.jpg?87phq https://www.catapult-ventures.com/news/pencil-biosciences-completes-fundraise-to-develop-novel-gene-editing-and-modulation-technology/ 2023-10-02T12:56:02+01:00 https://www.catapult-ventures.com/site/assets/files/1669/pencil_lab.jpg?824zu https://www.catapult-ventures.com/news/report-shows-yourmeds-medication-management-system-helped-councils-generate-significant-cost-savings/ 2023-09-25T13:58:21+01:00 https://www.catapult-ventures.com/site/assets/files/1668/yourmedpack_logo.png?7p96u https://www.catapult-ventures.com/news/maxwellia-launches-new-brand-of-emergency-contraception/ 2023-09-14T11:44:21+01:00 https://www.catapult-ventures.com/site/assets/files/1667/maxwellia_logotype_and_strapline_cmyk_2018.jpg?74ps3 https://www.catapult-ventures.com/news/gendius-receives-ukca-mark-for-ckd-screen-prioritizer/ 2023-09-04T14:55:38+01:00 https://www.catapult-ventures.com/site/assets/files/1666/gendius-logo-horizontal-large-dark_2x-100.jpg?6mfuy https://www.catapult-ventures.com/news/infex-receives-approval-for-dosing-final-resp-x-phase-ia-cohort-and-first-in-patient-phase-iia/ 2023-08-22T11:45:39+01:00 https://www.catapult-ventures.com/site/assets/files/1665/infex_logo.png?5y4i9 https://www.catapult-ventures.com/news/infex-therapeutics-clinical-candidate-nominated-for-cov-x-programme/ 2023-08-16T13:08:36+01:00 https://www.catapult-ventures.com/site/assets/files/1664/infex_logo_white_text.png?5n43h https://www.catapult-ventures.com/news/oxford-biotherapeutics-initiates-phase-ib-clinical-trial-for-obt076-in-patients-with-advanced-solid-tumours/ 2023-07-05T13:07:17+01:00 https://www.catapult-ventures.com/site/assets/files/1663/obt-rgb_1417_544.jpg?3hc6x https://www.catapult-ventures.com/news/cpi-enterprises-to-help-fund-innovative-medical-device-for-brain-tumours/ 2023-06-29T10:32:38+01:00 https://www.catapult-ventures.com/site/assets/files/1662/logo.png?360w0 https://www.catapult-ventures.com/news/ai-influencer-tackles-tiktok-health-trend/ 2023-06-15T14:43:34+01:00 https://www.catapult-ventures.com/site/assets/files/1661/maxwellia_logotype_and_strapline_cmyk_2018.jpg?2g4q5 https://www.catapult-ventures.com/news/cytox-brings-ground-breaking-genetic-risk-test-for-alzheimers-disease-to-the-uk-1/ 2023-06-15T10:56:19+01:00 https://www.catapult-ventures.com/site/assets/files/1660/cytox_logo_li.jpg?1xyd3 https://www.catapult-ventures.com/news/oxford-biotherapeutics-and-boehringer-ingelheim-agree-on-extension-to-second-multi-year-collaboration-in-cancer-immunology/ 2023-05-25T11:56:08+01:00 https://www.catapult-ventures.com/site/assets/files/1658/obt-rgb_500_192.jpg?1dbno https://www.catapult-ventures.com/news/study-by-healum-demonstrates-its-platform-improves-health-outcomes-for-diabetes-patients/ 2023-05-16T11:50:28+01:00 https://www.catapult-ventures.com/site/assets/files/1654/healum.png?wnea https://www.catapult-ventures.com/news/oxford-biotherapeutics-announces-phase-1b-trial-in-collaboration-with-gortec/ 2023-05-16T11:43:53+01:00 https://www.catapult-ventures.com/site/assets/files/1512/obt_logo.png?9czz https://www.catapult-ventures.com/news/infex-therapeutics-interim-results-demonstrate-a-favourable-safety-and-tolerability-profile-for-resp-x-in-ongoing-phas/ 2023-05-03T22:01:05+01:00 https://www.catapult-ventures.com/site/assets/files/1513/infex_logo.png?9czz https://www.catapult-ventures.com/news/qv-bioelectronics-awarded-860-000-innovate-uk-boost/ 2023-05-03T22:01:05+01:00 https://www.catapult-ventures.com/site/assets/files/1514/qvb_1500px_579px.png?9czz https://www.catapult-ventures.com/news/monument-therapeutics-to-present-positive-data-for-first-clinical-study-of-mt1980-a-novel-treatment-for-neuroinflamma/ 2023-05-03T22:01:06+01:00 https://www.catapult-ventures.com/site/assets/files/1515/monument_tx_logo.jpg?9d00 https://www.catapult-ventures.com/news/oxford-biotherapeutics-to-announce-new-fully-integrated-adc-engine-at-world-adc-conference-2023/ 2023-05-03T22:01:06+01:00 https://www.catapult-ventures.com/site/assets/files/1516/obt_logo.png?9d00 https://www.catapult-ventures.com/news/oxford-biotherapeutics-wins-tech-company-of-the-year-and-special-recognition-award/ 2023-05-03T22:00:52+01:00 https://www.catapult-ventures.com/site/assets/files/1507/obt_logo.png?9czm https://www.catapult-ventures.com/news/infex-therapeutics-strengthens-board-with-appointment-of-professor-colm-leonard-as-a-non-executive-director/ 2023-05-03T22:00:52+01:00 https://www.catapult-ventures.com/site/assets/files/1508/infexned.jpg?9czm https://www.catapult-ventures.com/news/healum-wins-nhs-contract-for-patients-at-risk-of-cvd/ 2023-05-03T22:00:52+01:00 https://www.catapult-ventures.com/site/assets/files/1509/healum.png?9czm https://www.catapult-ventures.com/news/qv-bioelectronics-raises-2m-to-develop-revolutionary-electric-field-therapy-implant-for-brain-tumour-treatment/ 2023-05-03T22:00:52+01:00 https://www.catapult-ventures.com/site/assets/files/1510/teamphotovertical2.jpg?9czm https://www.catapult-ventures.com/news/monument-therapeutics-announces-first-clinical-study-of-mt1980-successfully-meets-all-objectives/ 2023-05-03T22:00:53+01:00 https://www.catapult-ventures.com/site/assets/files/1511/monument_tx_logo.jpg?9czn https://www.catapult-ventures.com/news/infexs-novel-amr-drug-candidate-met-x-receives-fda-qidp-designation/ 2023-05-03T22:00:48+01:00 https://www.catapult-ventures.com/site/assets/files/1502/infex_logo.png?9czi https://www.catapult-ventures.com/news/diabetes-self-management-app-intellin-is-a-cost-effective-solution-for-preventing-diabetic-foot-ulcer-recurrence/ 2023-05-03T22:00:48+01:00 https://www.catapult-ventures.com/site/assets/files/1503/gendius-logo-horizontal-large-dark_2x-100.jpg?9czi https://www.catapult-ventures.com/news/pill-connectdispenser-supports-clinical-trial-for-personalised-tuberculosis-care/ 2023-05-03T22:00:48+01:00 https://www.catapult-ventures.com/site/assets/files/1504/702_pill-connect-logo-full-colour-rgb-1000px_72ppi.png?9czi https://www.catapult-ventures.com/news/extra-6.5m-secured-by-tech-firm-which-uses-ai-to-speed-up-scientific-discovery-as-it-eyes-us-expansion/ 2023-05-03T22:00:48+01:00 https://www.catapult-ventures.com/site/assets/files/1505/biorelate_new_2020.png?9czi https://www.catapult-ventures.com/news/blueberry-therapeutics-ltd-announces-nomination-of-bb1511-for-clinical-development-for-the-treatment-of-atopic-dermati/ 2023-05-03T22:00:48+01:00 https://www.catapult-ventures.com/site/assets/files/1506/blueberry_therapeutics_logo_rgb.jpg?9czi https://www.catapult-ventures.com/news/infex-enters-clinic-with-lead-anti-virulence-candidate-resp-x-for-pseudomonas-aeruginosa/ 2023-05-03T22:00:43+01:00 https://www.catapult-ventures.com/site/assets/files/1497/infex_logo.png?9czd https://www.catapult-ventures.com/news/biorelate-and-copyright-clearance-centre-announce-strategic-integration/ 2023-05-03T22:00:43+01:00 https://www.catapult-ventures.com/site/assets/files/1498/biorelate_new_2020.png?9czd https://www.catapult-ventures.com/news/first-choice-neurology-partners-with-cytox/ 2023-05-03T22:00:43+01:00 https://www.catapult-ventures.com/site/assets/files/1499/cytox_logo.jpeg?9czd https://www.catapult-ventures.com/news/oxford-biotherapeutics-enters-into-commercial-license-agreement-with-genmab/ 2023-05-03T22:00:43+01:00 https://www.catapult-ventures.com/site/assets/files/1500/obt-rgb_500_192.jpg?9czd https://www.catapult-ventures.com/news/gift-of-time-could-enable-nearly-100-more-kidney-transplants-each-year/ 2023-05-03T22:00:43+01:00 https://www.catapult-ventures.com/site/assets/files/1501/pebble_logo_cropped.jpg?9czd https://www.catapult-ventures.com/news/breakthrough-in-identifying-risk-of-renal-impairment-in-people-with-diabetes/ 2023-05-03T22:00:17+01:00 https://www.catapult-ventures.com/site/assets/files/1492/gendius-logo-horizontal-large-dark_2x-100.jpg?9cyn https://www.catapult-ventures.com/news/infex-therapeutics-awarded-biomedical-catalyst-grant-for-cov-x-project/ 2023-05-03T22:00:18+01:00 https://www.catapult-ventures.com/site/assets/files/1493/infex_logo.png?9cyo https://www.catapult-ventures.com/news/monument-therapeutics-presents-positive-preclinical-data-for-cognitive-impairment-in-schizophrenia-programme/ 2023-05-03T22:00:18+01:00 https://www.catapult-ventures.com/site/assets/files/1494/monument_tx_logo.jpg?9cyo https://www.catapult-ventures.com/news/microbiosensor-launches-quickcheck-designed-in-partnership-with-smallfry/ 2023-05-03T22:00:18+01:00 https://www.catapult-ventures.com/site/assets/files/1495/microbiosensor_quickcheck.jpg?9cyo https://www.catapult-ventures.com/news/iicon-to-expand-pipeline-following-research-england-funding-boost/ 2023-05-03T22:00:19+01:00 https://www.catapult-ventures.com/site/assets/files/1496/infex_logo.png?9cyp https://www.catapult-ventures.com/news/monument-therapeutics-announces-the-start-of-its-first-clinical-study-for-novel-treatment-for-neuroinflammation/ 2023-05-03T21:59:29+01:00 https://www.catapult-ventures.com/site/assets/files/1487/monument_tx_logo.jpg?9cxb https://www.catapult-ventures.com/news/oxford-biotherapeutics-announces-research-collaboration-with-immunogen-to-develop-novel-antibody-drug-conjugates/ 2023-05-03T21:59:29+01:00 https://www.catapult-ventures.com/site/assets/files/1488/obt-rgb_500_192.jpg?9cxb https://www.catapult-ventures.com/news/proveca-enters-an-exclusive-agreement-with-mawdsley-brooks-brazil/ 2023-05-03T21:59:29+01:00 https://www.catapult-ventures.com/site/assets/files/1489/proveca_logo.jpg?9cxb https://www.catapult-ventures.com/news/rinicares-safe-falls-reduction-technology-granted-new-uk-patent/ 2023-05-03T21:59:30+01:00 https://www.catapult-ventures.com/site/assets/files/1490/rinicare_logo_standard.jpg?9cxc https://www.catapult-ventures.com/news/trial-to-assess-acute-kidney-injury-risk-prediction-technology-starts-at-mft/ 2023-05-03T21:59:30+01:00 https://www.catapult-ventures.com/site/assets/files/1491/rinicare_logo_standard.jpg?9cxc https://www.catapult-ventures.com/news/oxford-biotherapeutics-to-present-initial-positive-data-from-phase-i-trial-at-asco-2022/ 2023-05-03T21:59:25+01:00 https://www.catapult-ventures.com/site/assets/files/1482/897_obt-rgb_500_192.jpg?9cx7 https://www.catapult-ventures.com/news/nihr-backed-ai-care-planning-network-goes-live/ 2023-05-03T21:59:25+01:00 https://www.catapult-ventures.com/site/assets/files/1483/healum.png?9cx7 https://www.catapult-ventures.com/news/oxford-biotherapeutics-announces-collaboration-with-agenus/ 2023-05-03T21:59:25+01:00 https://www.catapult-ventures.com/site/assets/files/1484/obt-rgb_500_192.jpg?9cx7 https://www.catapult-ventures.com/news/carb-x-receives-additional-370m-from-u.s-government-and-wellcome/ 2023-05-03T21:59:25+01:00 https://www.catapult-ventures.com/site/assets/files/1485/infex_logo.png?9cx7 https://www.catapult-ventures.com/news/blueberry-therapeutics-provides-regulatory-update-on-phase-2b-trial/ 2023-05-03T21:59:25+01:00 https://www.catapult-ventures.com/site/assets/files/1486/blueberry_therapeutics_logo_rgb.jpg?9cx7 https://www.catapult-ventures.com/news/infex-therapeutics-receives-mhra-approval-to-initiate-phase-1-study-for-resp-x-programme/ 2023-05-03T21:59:20+01:00 https://www.catapult-ventures.com/site/assets/files/1477/infex_logo.png?9cx2 https://www.catapult-ventures.com/news/maxwellia-appoints-ian-adamson-as-strategic-advisor/ 2023-05-03T21:59:20+01:00 https://www.catapult-ventures.com/site/assets/files/1478/maxwellia_ian-adamson-696x557.jpg?9cx2 https://www.catapult-ventures.com/news/catapult-ventures-records-3.3x-return-from-exit-of-panthera-biopartners/ 2023-05-03T21:59:20+01:00 https://www.catapult-ventures.com/site/assets/files/1479/panthera-corporate-black_on_white.png?9cx2 https://www.catapult-ventures.com/news/medicine-switching-expert-maxwellia-continues-to-drive-shift-to-self-care-with-two-more-pharmacy-products-in-the-launc/ 2023-05-03T21:59:21+01:00 https://www.catapult-ventures.com/site/assets/files/1480/maxwellia_logotype_and_strapline_2018_1.png?9cx3 https://www.catapult-ventures.com/news/oxford-biotherapeutics-grants-third-exclusive-license-to-boehringer-ingelheim/ 2023-05-03T21:59:21+01:00 https://www.catapult-ventures.com/site/assets/files/1481/897_obt-rgb_500_192.jpg?9cx3 https://www.catapult-ventures.com/news/obt-to-present-preliminary-clinical-data-from-ongoing-expansion-phase-i-trial/ 2023-05-03T21:59:14+01:00 https://www.catapult-ventures.com/site/assets/files/1472/897_obt-rgb_500_192.jpg?9cww https://www.catapult-ventures.com/news/proveca-announces-agreement-with-biopas-laboratories/ 2023-05-03T21:59:15+01:00 https://www.catapult-ventures.com/site/assets/files/1473/proveca_logo.jpg?9cwx https://www.catapult-ventures.com/news/cell-guidance-systems-and-manchester-biogel-collaborate-to-launch-pods-peptigels-for-3d-cell-culture/ 2023-05-03T21:59:15+01:00 https://www.catapult-ventures.com/site/assets/files/1474/manchester_biogel_logo_wht_rgb.jpg?9cwx https://www.catapult-ventures.com/news/pill-connect-releases-adherence-data-to-demonstrate-efficacy-of-smart-dosing-technology/ 2023-05-03T21:59:15+01:00 https://www.catapult-ventures.com/site/assets/files/1475/pillconnect_devices.jpg?9cwx https://www.catapult-ventures.com/news/blueberry-therapeutics-provides-r-d-update-and-reports-progress-across-dermatology-portfolio/ 2023-05-03T21:59:15+01:00 https://www.catapult-ventures.com/site/assets/files/1476/blueberry_therapeutics_logo_rgb.jpg?9cwx https://www.catapult-ventures.com/news/you-type-2-diabetes-project-helps-transform-patient-experiences-supported-by-healum-technology/ 2023-05-03T21:59:09+01:00 https://www.catapult-ventures.com/site/assets/files/1467/healum.png?9cwr https://www.catapult-ventures.com/news/panthera-wins-contract-to-recruit-patients-for-roche-breast-cancer-study/ 2023-05-03T21:59:09+01:00 https://www.catapult-ventures.com/site/assets/files/1468/panthera-corporate-black_on_white.png?9cwr https://www.catapult-ventures.com/news/trio-healthcare-liberates-patients-with-new-breathable-silicone-bag/ 2023-05-03T21:59:10+01:00 https://www.catapult-ventures.com/site/assets/files/1469/trio-logo.jpg?9cws https://www.catapult-ventures.com/news/stratified-medicine-company-monument-therapeutics-announces-two-new-developments/ 2023-05-03T21:59:10+01:00 https://www.catapult-ventures.com/site/assets/files/1470/monument_tx_logo.jpg?9cws https://www.catapult-ventures.com/news/nice-releases-medtech-innovation-briefing-for-yourmeds-smart-medication-management-system/ 2023-05-03T21:59:10+01:00 https://www.catapult-ventures.com/site/assets/files/1471/yourmedpack_logo.png?9cws https://www.catapult-ventures.com/news/proveca-announces-new-partnership-with-exceed-orphan/ 2023-05-03T21:59:05+01:00 https://www.catapult-ventures.com/site/assets/files/1462/proveca_logo.jpg?9cwn https://www.catapult-ventures.com/news/gendius-initiates-gp-data-study-to-develop-enhanced-risk-prediction-tools-for-diabetes/ 2023-05-03T21:59:05+01:00 https://www.catapult-ventures.com/site/assets/files/1463/gendius_logo.jpg?9cwn https://www.catapult-ventures.com/news/qv-bioelectronics-awarded-630-000-under-innovate-uk-biomedical-catalyst-award/ 2023-05-03T21:59:06+01:00 https://www.catapult-ventures.com/site/assets/files/1464/qvb_1500px_579px.png?9cwo https://www.catapult-ventures.com/news/two-new-senior-appointments-at-manchester-imaging/ 2023-05-03T21:59:06+01:00 https://www.catapult-ventures.com/site/assets/files/1465/manchester_imaging_logo.jpg?9cwo https://www.catapult-ventures.com/news/alder-hey-childrens-hospital-and-proveca-announce-collaboration/ 2023-05-03T21:59:06+01:00 https://www.catapult-ventures.com/site/assets/files/1466/proveca_logo.jpg?9cwo https://www.catapult-ventures.com/news/monument-therapeutics-raises-additional-0.5-million-to-take-anti-neuroinflammation-candidate-mt1980-into-clinic/ 2023-05-03T21:59:01+01:00 https://www.catapult-ventures.com/site/assets/files/1457/monument_tx_logo.jpg?9cwj https://www.catapult-ventures.com/news/infex-therapeutics-agrees-partnership-with-colibri-scientific-to-provide-services-for-resp-x-program/ 2023-05-03T21:59:02+01:00 https://www.catapult-ventures.com/site/assets/files/1458/infex_logo.png?9cwk https://www.catapult-ventures.com/news/panthera-biopartners-leads-the-way-in-the-uk-with-specialist-research-sites-for-nash-and-nafld-studies/ 2023-05-03T21:59:02+01:00 https://www.catapult-ventures.com/site/assets/files/1459/panthera-corporate-black_on_white.png?9cwk https://www.catapult-ventures.com/news/infex-therapeutics-scientists-achieve-breakthrough-with-potential-new-drug-for-omicron-and-new-coronavirus-strains/ 2023-05-03T21:59:02+01:00 https://www.catapult-ventures.com/site/assets/files/1460/infex_logo.png?9cwk https://www.catapult-ventures.com/news/proveca-sponsored-clinical-trial-starts-in-france-to-evaluate-the-impact-of-its-drug-sialanar/ 2023-05-03T21:59:02+01:00 https://www.catapult-ventures.com/site/assets/files/1461/proveca_logo.jpg?9cwk https://www.catapult-ventures.com/news/manchester-biogel-and-resnova-to-sign-a-strategic-agreement-for-the-distribution-in-italy-of-innovative-solutions-for/ 2023-05-03T21:58:58+01:00 https://www.catapult-ventures.com/site/assets/files/1452/manchester_biogel_logo_wht_rgb.jpg?9cwg https://www.catapult-ventures.com/news/rinicare-enters-data-sharing-collaboration-with-manchester-university-nhs-foundation-trust-to-further-develop-clinical/ 2023-05-03T21:58:58+01:00 https://www.catapult-ventures.com/site/assets/files/1453/rinicare_logo_standard.jpg?9cwg https://www.catapult-ventures.com/news/trio-healthcare-takes-leap-forward-in-international-growth-strategy-by-opening-first-office-in-us/ 2023-05-03T21:58:58+01:00 https://www.catapult-ventures.com/site/assets/files/1454/trio-logo.jpg?9cwg https://www.catapult-ventures.com/news/biofortuna-relocates-to-purpose-built-facilities-and-more-than-doubles-its-capacity/ 2023-05-03T21:58:58+01:00 https://www.catapult-ventures.com/site/assets/files/1455/biofortuna-logo-2018-rgb.jpg?9cwg https://www.catapult-ventures.com/news/panthera-therutherford-partnership-commences-first-uk-multicentre-oncology-trial-in-prostate-cancer/ 2023-05-03T21:58:58+01:00 https://www.catapult-ventures.com/site/assets/files/1456/panthera-corporate-black_on_white.png?9cwg https://www.catapult-ventures.com/news/adept-study-proves-value-of-dental-ai-using-assistdent-ai-software/ 2023-05-03T21:58:54+01:00 https://www.catapult-ventures.com/site/assets/files/1447/manchester_imaging_logo.jpg?9cwc https://www.catapult-ventures.com/news/rinicare-confirms-first-european-evaluation-of-its-ai-falls-prevention-technology/ 2023-05-03T21:58:54+01:00 https://www.catapult-ventures.com/site/assets/files/1448/rinicare_logo_standard.jpg?9cwc https://www.catapult-ventures.com/news/channel-4-ventures-invests-in-maxwellia-to-support-the-launch-of-lovima/ 2023-05-03T21:58:54+01:00 https://www.catapult-ventures.com/site/assets/files/1449/maxwellia_logotype_and_strapline_2018_1.png?9cwc https://www.catapult-ventures.com/news/maxwellia-announces-appointment-of-sara-al-attbi-as-medical-affairs-pharmacist/ 2023-05-03T21:58:55+01:00 https://www.catapult-ventures.com/site/assets/files/1450/maxwellia_sara_al-attbi.jpg?9cwd https://www.catapult-ventures.com/news/infinity-biologix-cytox-and-vanguard-pharma-announce-the-us-launch-of-polygenic-test-to-predict-the-risk-of-cognitiv/ 2023-05-03T21:58:55+01:00 https://www.catapult-ventures.com/site/assets/files/1451/cytox_logo.jpeg?9cwd https://www.catapult-ventures.com/news/new-study-launched-to-investigate-targeted-treatments-for-schizophrenia/ 2023-05-03T21:58:50+01:00 https://www.catapult-ventures.com/site/assets/files/1442/monument_tx_logo.jpg?9cw8 https://www.catapult-ventures.com/news/boehringer-ingelheim-and-oxford-biotherapeutics-partnership-advances-second-oncology-drug-candidate-into-the-clinic/ 2023-05-03T21:58:51+01:00 https://www.catapult-ventures.com/site/assets/files/1443/obt-rgb_500_192.jpg?9cw9 https://www.catapult-ventures.com/news/maxwellia-strengthens-its-marketing-team-with-two-new-appointments/ 2023-05-03T21:58:51+01:00 https://www.catapult-ventures.com/site/assets/files/1444/maxwellia_marketing_team.jpg?9cw9 https://www.catapult-ventures.com/news/rinicares-continuous-vital-signs-monitoring-technology-deployed-across-hospitals-and-covid-19-health-centres-in-ind/ 2023-05-03T21:58:51+01:00 https://www.catapult-ventures.com/site/assets/files/1445/rinicare_india.jpeg?9cw9 https://www.catapult-ventures.com/news/2m-funding-boost-for-infexs-work-on-pandemic-preparedness/ 2023-05-03T21:58:51+01:00 https://www.catapult-ventures.com/site/assets/files/1446/infextx.jpg?9cw9 https://www.catapult-ventures.com/news/rinicare-launches-new-ai-driven-risk-prediction-solution-for-atrial-fibrillation/ 2023-05-03T21:58:46+01:00 https://www.catapult-ventures.com/site/assets/files/1437/rinicare_stability-af-image.png?9cw4 https://www.catapult-ventures.com/news/viscgo-completes-315k-investment-round/ 2023-05-03T21:58:46+01:00 https://www.catapult-ventures.com/site/assets/files/1438/viscgo_drinks.jpg?9cw4 https://www.catapult-ventures.com/news/clin-e-cal-wins-share-of-4m-tech-fund-to-revolutionise-asthma-self-management/ 2023-05-03T21:58:47+01:00 https://www.catapult-ventures.com/site/assets/files/1439/clinecal_logo.png?9cw5 https://www.catapult-ventures.com/news/panthera-steps-up-its-move-into-oncology-trials-with-more-than-12-trials-in-the-pipeline-and-a-prostate-trial-underway/ 2023-05-03T21:58:47+01:00 https://www.catapult-ventures.com/site/assets/files/1440/panthera_rutherford_centre.jpg?9cw5 https://www.catapult-ventures.com/news/gendius-to-collaborate-with-the-university-of-manchester-on-new-human-ai-research-teams/ 2023-05-03T21:58:47+01:00 https://www.catapult-ventures.com/site/assets/files/1441/gendius_logo.jpg?9cw5 https://www.catapult-ventures.com/news/infex-therapeutics-sharpens-covid-focus-with-new-cruk-newcastle-partnership/ 2023-05-03T21:58:42+01:00 https://www.catapult-ventures.com/site/assets/files/1432/infex_logo.png?9cw0 https://www.catapult-ventures.com/news/cytox-strengthens-team-to-support-commercialisation-of-genoscore-test-to-predict-risk-of-cognitive-decline-due-to-alzh/ 2023-05-03T21:58:43+01:00 https://www.catapult-ventures.com/site/assets/files/1433/cytox_logo.jpeg?9cw1 https://www.catapult-ventures.com/news/women-can-buy-maxwellias-lovima-contraceptive-pill-from-pharmacies-for-first-time-in-uk-history/ 2023-05-03T21:58:43+01:00 https://www.catapult-ventures.com/site/assets/files/1434/maxwellia_logotype_and_strapline_2018_1.png?9cw1 https://www.catapult-ventures.com/news/qv-bioelectronics-raises-735k-for-development-of-implanted-electric-field-therapy-device-for-brain-cancer-treatment/ 2023-05-03T21:58:43+01:00 https://www.catapult-ventures.com/site/assets/files/1435/qvb_team.jpg?9cw1 https://www.catapult-ventures.com/news/gendius-new-partnership-will-help-diabetics-to-manage-their-conditions/ 2023-05-03T21:58:43+01:00 https://www.catapult-ventures.com/site/assets/files/1436/gendius_logo.jpg?9cw1 https://www.catapult-ventures.com/news/cambridge-cognition-completes-spin-out-of-monument-therapeutics/ 2023-05-03T21:58:38+01:00 https://www.catapult-ventures.com/site/assets/files/1427/monument_tx_logo.jpg?9cvw https://www.catapult-ventures.com/news/infinity-biologix-and-cytox-collaborate-to-provide-new-genetic-test-to-predict-the-risk-of-cognitive-decline-due-to-al/ 2023-05-03T21:58:38+01:00 https://www.catapult-ventures.com/site/assets/files/1428/cytox_infinitybio_collab.jpg?9cvw https://www.catapult-ventures.com/news/rinicare-to-provide-continuous-vital-signs-monitoring-technology-to-indian-healthcare-system/ 2023-05-03T21:58:38+01:00 https://www.catapult-ventures.com/site/assets/files/1429/rinicare_logo.png?9cvw https://www.catapult-ventures.com/news/innovate-uk-funds-assistdent-adaption-for-university-dental-schools/ 2023-05-03T21:58:39+01:00 https://www.catapult-ventures.com/site/assets/files/1430/manchester_imaging_logo.jpg?9cvx https://www.catapult-ventures.com/news/blueberry-therapeutics-secures-further-investment/ 2023-05-03T21:58:39+01:00 https://www.catapult-ventures.com/site/assets/files/1431/blueberry_therapeutics_logo_rgb.jpg?9cvx https://www.catapult-ventures.com/news/infex-therapeutics-partners-with-alderley-analytical/ 2023-05-03T21:58:34+01:00 https://www.catapult-ventures.com/site/assets/files/1422/infex_logo.png?9cvs https://www.catapult-ventures.com/news/infex-therapeutics-appoints-lonza-to-manufacture-new-lung-infection-drug/ 2023-05-03T21:58:34+01:00 https://www.catapult-ventures.com/site/assets/files/1423/infex_logo.png?9cvs https://www.catapult-ventures.com/news/digital-health-start-up-clin-e-cal-launches-free-app-to-help-improve-inhaler-technique-and-reduce-asthma-attacks/ 2023-05-03T21:58:34+01:00 https://www.catapult-ventures.com/site/assets/files/1424/clin_e_cal_free_app.jpg?9cvs https://www.catapult-ventures.com/news/british-pharmaceutical-company-maxwellia-secures-government-future-fund-investment-to-spearhead-shift-in-self-care/ 2023-05-03T21:58:34+01:00 https://www.catapult-ventures.com/site/assets/files/1425/maxwellia_logotype_and_strapline_2018_1.png?9cvs https://www.catapult-ventures.com/news/viscgo-secures-investment-to-launch-its-innovative-device-to-improve-quality-of-life-for-people-with-swallowing-diffic/ 2023-05-03T21:58:35+01:00 https://www.catapult-ventures.com/site/assets/files/1426/viscgo_ceo_sml.jpg?9cvt https://www.catapult-ventures.com/news/panthera-becomes-the-worlds-first-clinical-trial-site-to-administer-valnevas-inactivated-covid-19-vaccine-vla20/ 2023-05-03T21:58:30+01:00 https://www.catapult-ventures.com/site/assets/files/1417/panthera_team_apr_21.jpg?9cvo https://www.catapult-ventures.com/news/maxwellia-on-course-to-launch-self-care-alternatives-following-3.2m-funding-round/ 2023-05-03T21:58:30+01:00 https://www.catapult-ventures.com/site/assets/files/1418/maxwellia_logotype_and_strapline_2018_1.png?9cvo https://www.catapult-ventures.com/news/deals-agreed-as-infexs-resistance-bypass-drug-program-heads-for-clinic/ 2023-05-03T21:58:30+01:00 https://www.catapult-ventures.com/site/assets/files/1419/infex_logo.png?9cvo https://www.catapult-ventures.com/news/panthera-biopartners-appoints-corporate-financier-christopher-steed-as-a-non-executive-director-to-continue-uk-and-ove/ 2023-05-03T21:58:30+01:00 https://www.catapult-ventures.com/site/assets/files/1420/panthera_chris-steed-150x150.jpg?9cvo https://www.catapult-ventures.com/news/infex-focuses-on-pandemic-preparedness-with-covid-patent/ 2023-05-03T21:58:31+01:00 https://www.catapult-ventures.com/site/assets/files/1421/infex_logo.png?9cvp https://www.catapult-ventures.com/news/healum-closes-investment-round-to-develop-ukri-funded-ai-powered-patient-management-system-for-people-with-long-term-c/ 2023-05-03T21:58:26+01:00 https://www.catapult-ventures.com/site/assets/files/1412/0z7a1605_3_2.jpg?9cvk https://www.catapult-ventures.com/news/panthera-biopartners-commences-a-ph-3-trial-for-astrazenecas-monoclonal-antibody-combination-to-reduce-the-effects/ 2023-05-03T21:58:26+01:00 https://www.catapult-ventures.com/site/assets/files/1413/panthera-corporate-black_on_white.png?9cvk https://www.catapult-ventures.com/news/uk-healthtech-startup-rinicare-appoints-leading-ai-and-machine-learning-specialist-as-chief-technology-and-data-office/ 2023-05-03T21:58:26+01:00 https://www.catapult-ventures.com/site/assets/files/1414/rinicare_miguel_mandao.png?9cvk https://www.catapult-ventures.com/news/panthera-further-strengthens-its-oncology-clinical-trials-team-with-the-appointment-of-matt-cooper-as-general-manager/ 2023-05-03T21:58:26+01:00 https://www.catapult-ventures.com/site/assets/files/1415/panthera-corporate-black_on_white.png?9cvk https://www.catapult-ventures.com/news/biorelate-signs-multi-year-deal-with-e-therapeutics/ 2023-05-03T21:58:26+01:00 https://www.catapult-ventures.com/site/assets/files/1416/biorelate_etherapeutics.jpg?9cvk https://www.catapult-ventures.com/news/cytox-launches-genoscore-lab-test-to-predict-the-risk-of-developing-alzheimers-disease/ 2023-05-03T21:58:21+01:00 https://www.catapult-ventures.com/site/assets/files/1407/cytox_logo.jpeg?9cvf https://www.catapult-ventures.com/news/the-pill-could-be-sold-in-pharmacies-without-prescription/ 2023-05-03T21:58:22+01:00 https://www.catapult-ventures.com/site/assets/files/1408/maxwellia_logotype_and_strapline_2018_1.png?9cvg https://www.catapult-ventures.com/news/maxwellia-spearheading-shift-to-self-care-with-three-pharmacy-products-in-launch-pipeline/ 2023-05-03T21:58:22+01:00 https://www.catapult-ventures.com/site/assets/files/1409/maxwellia_logotype_and_strapline_2018_1.png?9cvg https://www.catapult-ventures.com/news/maxwellia-announces-appointment-of-tim-holmes-as-head-of-sales/ 2023-05-03T21:58:22+01:00 https://www.catapult-ventures.com/site/assets/files/1410/maxwellia_tim_holmes.jpg?9cvg https://www.catapult-ventures.com/news/aardex-group-and-pill-connect-ltd-partner-to-empower-patient-adherence/ 2023-05-03T21:58:22+01:00 https://www.catapult-ventures.com/site/assets/files/1411/pill_connect_aardex.png?9cvg https://www.catapult-ventures.com/news/blueberry-therapeutics-announces-extension-of-its-series-b-round-with-investment-from-medical-incubator-japan-and-us-d/ 2023-05-03T21:58:18+01:00 https://www.catapult-ventures.com/site/assets/files/1402/blueberry_therapeutics_logo_rgb.jpg?9cvc https://www.catapult-ventures.com/news/chris-hall-elected-chairman-of-pill-connect/ 2023-05-03T21:58:18+01:00 https://www.catapult-ventures.com/site/assets/files/1403/chrispillconnect-2.png?9cvc https://www.catapult-ventures.com/news/panthera-continues-to-sign-up-new-clinical-trials-across-its-uk-network-of-dedicated-clinical-trial-sites/ 2023-05-03T21:58:18+01:00 https://www.catapult-ventures.com/site/assets/files/1404/panthera-corporate-black_on_white.png?9cvc https://www.catapult-ventures.com/news/manchester-imaging-teams-up-with-michelson-diagnostics/ 2023-05-03T21:58:18+01:00 https://www.catapult-ventures.com/site/assets/files/1405/manchester_imaging_logo.jpg?9cvc https://www.catapult-ventures.com/news/oxford-biotherapeutics-designates-second-bispecific-antibody-program-leveraging-wuxi-biologics-wuxibody-platform/ 2023-05-03T21:58:18+01:00 https://www.catapult-ventures.com/site/assets/files/1406/obt_logo_new.png?9cvc https://www.catapult-ventures.com/news/maxwellia-announces-appointment-of-jack-grimshaw-as-finance-director/ 2023-05-03T21:58:12+01:00 https://www.catapult-ventures.com/site/assets/files/1397/maxwellia_jack-grimshaw.png?9cv6 https://www.catapult-ventures.com/news/funding-package-announced-for-blister-prevention-firm-pellitec/ 2023-05-03T21:58:14+01:00 https://www.catapult-ventures.com/site/assets/files/1398/pellitec-layers.gif?9cv8 https://www.catapult-ventures.com/news/kite-and-oxford-biotherapeutics-establish-cell-therapy-research-collaboration-in-blood-cancers-and-solid-tumours/ 2023-05-03T21:58:14+01:00 https://www.catapult-ventures.com/site/assets/files/1399/obt_logo_new.png?9cv8 https://www.catapult-ventures.com/news/panthera-assists-in-astrazenecas-phase-iii-trial-of-antibody-combination-for-prevention-of-covid-19/ 2023-05-03T21:58:14+01:00 https://www.catapult-ventures.com/site/assets/files/1400/panthera-corporate-black_on_white.png?9cv8 https://www.catapult-ventures.com/news/british-medtech-rinicare-poised-to-respond-to-the-challenges-of-the-new-healthcare-environment/ 2023-05-03T21:58:14+01:00 https://www.catapult-ventures.com/site/assets/files/1401/rinicare_anthony_holmes.png?9cv8 https://www.catapult-ventures.com/news/pill-connect-expands-its-team-with-the-appointment-of-richard-hall-as-director-of-quality/ 2023-05-03T21:58:08+01:00 https://www.catapult-ventures.com/site/assets/files/1392/702_pill-connect-logo-full-colour-rgb-1000px_72ppi.png?9cv2 https://www.catapult-ventures.com/news/catapult-ventures-invests-in-ovo-biomanufacturing-to-improve-the-manufacturing-efficiency-of-viral-vaccines-and-gene-t/ 2023-05-03T21:58:08+01:00 https://www.catapult-ventures.com/site/assets/files/1393/vijay_c_website.jpg?9cv2 https://www.catapult-ventures.com/news/exciting-new-collaboration-to-develop-fully-synthetic-animal-free-scaffolds/ 2023-05-03T21:58:08+01:00 https://www.catapult-ventures.com/site/assets/files/1394/manchester_biogel_logo_wht_rgb.jpg?9cv2 https://www.catapult-ventures.com/news/maven-equity-finance-npif-invests-alongside-catapult-in-digital-healthcare-consent-platform-flynotes/ 2023-05-03T21:58:08+01:00 https://www.catapult-ventures.com/site/assets/files/1395/631_acea_flynotes_2020_logo.png?9cv2 https://www.catapult-ventures.com/news/maxwellia-looking-into-daily-contraceptive-rx-to-otc-switch/ 2023-05-03T21:58:08+01:00 https://www.catapult-ventures.com/site/assets/files/1396/maxwellia_logotype_and_strapline_2018_1.png?9cv2 https://www.catapult-ventures.com/news/digi.me-partners-with-gendius-to-allow-users-to-connect-their-health-records-to-its-smart-diabetes-management-platform/ 2023-05-03T21:58:04+01:00 https://www.catapult-ventures.com/site/assets/files/1387/gendius_logo.jpg?9cuy https://www.catapult-ventures.com/news/cytox-publishes-research-showing-genoscore-lab-test-can-predict-risk-of-cognitive-decline-due-to-alzheimers-without/ 2023-05-03T21:58:04+01:00 https://www.catapult-ventures.com/site/assets/files/1388/cytox_brain.jpg?9cuy https://www.catapult-ventures.com/news/the-medication-adherence-expertise-center-and-pill-connects-smart-adherence-system-help-patients-with-tb-take-their/ 2023-05-03T21:58:04+01:00 https://www.catapult-ventures.com/site/assets/files/1389/pill_connect_phone_bottle.png?9cuy https://www.catapult-ventures.com/news/infex-therapeutics-and-lifearc-announce-collaboration-to-defeat-superbugs/ 2023-05-03T21:58:05+01:00 https://www.catapult-ventures.com/site/assets/files/1390/infex_logo.png?9cuz https://www.catapult-ventures.com/news/biorelate-ai-based-drug-discovery-tool-free-access-extended/ 2023-05-03T21:58:05+01:00 https://www.catapult-ventures.com/site/assets/files/1391/biorelate_new_2020.png?9cuz https://www.catapult-ventures.com/news/biotech-investor-backs-electronic-smart-pill-bottle-pill-connect/ 2023-05-03T21:58:00+01:00 https://www.catapult-ventures.com/site/assets/files/1382/pill_connect_phone_bottle.png?9cuu https://www.catapult-ventures.com/news/north-west-entrepreneurs-secure-inclusion-on-international-wellbeing-accelerator-programme/ 2023-05-03T21:58:00+01:00 https://www.catapult-ventures.com/site/assets/files/1383/tectores_pellitec-logo.png?9cuu https://www.catapult-ventures.com/news/cytox-appoints-yourgene-genomic-services-as-european-partner/ 2023-05-03T21:58:00+01:00 https://www.catapult-ventures.com/site/assets/files/1384/cytox_logo.jpeg?9cuu https://www.catapult-ventures.com/news/medicine-adherence-and-compliance-innovation-yourmeds-wins-seas2grow-award-in-agetech-accelerator-programme/ 2023-05-03T21:58:00+01:00 https://www.catapult-ventures.com/site/assets/files/1385/yourmedpack_logo.png?9cuu https://www.catapult-ventures.com/news/face-mask-firm-virustatic-expands-and-signs-international-distribution-deals/ 2023-05-03T21:58:01+01:00 https://www.catapult-ventures.com/site/assets/files/1386/virustatic_team_photo.jpeg?9cuv https://www.catapult-ventures.com/news/boehringer-ingelheim-and-oxford-biotherapeutics-expand-collaboration/ 2023-05-03T21:57:55+01:00 https://www.catapult-ventures.com/site/assets/files/1377/obt-rgb_500_192.jpg?9cup https://www.catapult-ventures.com/news/crowdcube-success-for-clin-e-cal/ 2023-05-03T21:57:55+01:00 https://www.catapult-ventures.com/site/assets/files/1378/clin_e_cal_crowdcube_2020_campaign.jpg?9cup https://www.catapult-ventures.com/news/intellin-wins-at-health-tech-digital-awards/ 2023-05-03T21:57:55+01:00 https://www.catapult-ventures.com/site/assets/files/1379/social-media-announcement-htd-awards-2020-min-1.png?9cup https://www.catapult-ventures.com/news/flynotes-dental-fallow-time-calculator-to-be-launched/ 2023-05-03T21:57:55+01:00 https://www.catapult-ventures.com/site/assets/files/1380/631_acea_flynotes_2020_logo.png?9cup https://www.catapult-ventures.com/news/study-shows-clement-clarkes-clip-tone-device-improves-inhaler-technique/ 2023-05-03T21:57:55+01:00 https://www.catapult-ventures.com/site/assets/files/1381/cliptone.jpg?9cup https://www.catapult-ventures.com/news/catapult-ventures-announces-investment-in-panthera-biopartners/ 2023-05-03T21:57:50+01:00 https://www.catapult-ventures.com/site/assets/files/1372/panthera-corporate-black_on_white.png?9cuk https://www.catapult-ventures.com/news/covid-19-pandemic-spurs-adoption-and-investment-in-digital-health-technologies/ 2023-05-03T21:57:50+01:00 https://www.catapult-ventures.com/site/assets/files/1373/gareth_website.jpg?9cuk https://www.catapult-ventures.com/news/cytox-signs-licence-agreement-with-cardiff-university-for-polygenic-risk-score-technology-key-to-development-of-lead-p/ 2023-05-03T21:57:50+01:00 https://www.catapult-ventures.com/site/assets/files/1374/cytox_jigsaw.jpg?9cuk https://www.catapult-ventures.com/news/clin-e-cal-launches-crowdcube-campaign/ 2023-05-03T21:57:51+01:00 https://www.catapult-ventures.com/site/assets/files/1375/clinecal_logo.png?9cul https://www.catapult-ventures.com/news/catapult-ventures-announces-investment-in-digital-health-start-up-myhelp/ 2023-05-03T21:57:51+01:00 https://www.catapult-ventures.com/site/assets/files/1376/emma_website.jpg?9cul https://www.catapult-ventures.com/news/catapult-ventures-invests-in-agricultural-synthetic-biology-start-up-crobio/ 2023-05-03T21:57:45+01:00 https://www.catapult-ventures.com/site/assets/files/1367/crobio.jpg?9cuf https://www.catapult-ventures.com/news/catapult-announces-the-sale-of-oracle-care-education/ 2023-05-03T21:57:45+01:00 https://www.catapult-ventures.com/site/assets/files/1368/oracle_care.jpg?9cuf https://www.catapult-ventures.com/news/yourmedpack-announces-growth-funding-from-catapult-ventures-for-smart-medication-packs/ 2023-05-03T21:57:46+01:00 https://www.catapult-ventures.com/site/assets/files/1369/yourmeds2.png?9cug https://www.catapult-ventures.com/news/gendius-awarded-a-share-of-200-000-through-health-innovation-manchester-momentum-fund/ 2023-05-03T21:57:46+01:00 https://www.catapult-ventures.com/site/assets/files/1370/intellin-v2_showcase9.jpg?9cug https://www.catapult-ventures.com/news/major-boost-in-global-fight-against-antimicrobial-resistance-as-amr-centre-receives-share-of-strength-in-places-fund-a/ 2023-05-03T21:57:46+01:00 https://www.catapult-ventures.com/site/assets/files/1371/amr_centre_logo.jpg?9cug https://www.catapult-ventures.com/news/gendius-partners-with-astrazeneca-to-develop-diabetes-management-support-for-patients-in-the-gulf-region/ 2023-05-03T21:57:41+01:00 https://www.catapult-ventures.com/site/assets/files/1362/az-intellin_2020_full-768x625.jpg?9cub https://www.catapult-ventures.com/news/elucid-digital-health-and-clin-e-cal-feature-in-the-business-cloud-100-healthtech-pioneers-list/ 2023-05-03T21:57:41+01:00 https://www.catapult-ventures.com/site/assets/files/1363/100healthtech.jpg?9cub https://www.catapult-ventures.com/news/gendius-announces-launch-of-crowdcube-campaign-for-intellin-diabetes-management-app/ 2023-05-03T21:57:41+01:00 https://www.catapult-ventures.com/site/assets/files/1364/intellin-v2_showcase9.jpg?9cub https://www.catapult-ventures.com/news/biorelate-offers-free-access-to-ai-based-drug-discovery-tool-galactic/ 2023-05-03T21:57:41+01:00 https://www.catapult-ventures.com/site/assets/files/1365/biorelate_new_2020.png?9cub https://www.catapult-ventures.com/news/collaboration-between-clin-e-cal-and-clement-clarke-international-aims-to-make-inhalers-smarter/ 2023-05-03T21:57:42+01:00 https://www.catapult-ventures.com/site/assets/files/1366/sound_response_graphic.png?9cub https://www.catapult-ventures.com/news/elucid-digital-health-reduces-smart-pill-connect-bottle-to-a-smart-cap-dispenser/ 2023-05-03T21:57:37+01:00 https://www.catapult-ventures.com/site/assets/files/1357/elucid_phone_bottle_3_2020.png?9cu7 https://www.catapult-ventures.com/news/medtech-start-up-gendius-appoints-new-chairman-as-its-smart-diabetes-management-app-reaches-100-000-downloads-worldwid/ 2023-05-03T21:57:37+01:00 https://www.catapult-ventures.com/site/assets/files/1358/gendius_albert-nicholl.jpg?9cu7 https://www.catapult-ventures.com/news/catapult-ventures-appoints-vijay-curthan-as-investment-director-promotes-emma-johnson-to-associate/ 2023-05-03T21:57:37+01:00 https://www.catapult-ventures.com/site/assets/files/1359/catapult_ventures_cymk_hres_med.jpg?9cu7 https://www.catapult-ventures.com/news/trials-are-ramped-up-for-breakthrough-medical-device-from-microbiosensor/ 2023-05-03T21:57:37+01:00 https://www.catapult-ventures.com/site/assets/files/1360/microbiosensor_quick_check.jpg?9cu7 https://www.catapult-ventures.com/news/intellin-diabetes-app-enhanced-to-capture-covid-19-data/ 2023-05-03T21:57:37+01:00 https://www.catapult-ventures.com/site/assets/files/1361/gendius_logo.jpg?9cu7 https://www.catapult-ventures.com/news/clin-e-cal-rafi-tone-app-listed-in-the-covid19-health-app-formulary/ 2023-05-03T21:57:31+01:00 https://www.catapult-ventures.com/site/assets/files/1352/clin-e-cal_rafitone_game.jpg?9cu1 https://www.catapult-ventures.com/news/obt-achieves-further-milestone-in-boehringer-ingelheim-collaboration/ 2023-05-03T21:57:31+01:00 https://www.catapult-ventures.com/site/assets/files/1353/897_obt-rgb_500_192.jpg?9cu1 https://www.catapult-ventures.com/news/microbiosensor-new-device-for-treatment-of-peritonitis-undergoes-clinical-trials/ 2023-05-03T21:57:32+01:00 https://www.catapult-ventures.com/site/assets/files/1354/microbiosensor_nostrap_cmyk.jpg?9cu2 https://www.catapult-ventures.com/news/the-amr-centre-signs-agreement-with-microbiotix-to-co-develop-treatment-for-gonorrhoea/ 2023-05-03T21:57:32+01:00 https://www.catapult-ventures.com/site/assets/files/1355/amrcentre_logo_white.jpg?9cu2 https://www.catapult-ventures.com/news/blueberry-therapeutics-announces-new-clinical-science-lead/ 2023-05-03T21:57:32+01:00 https://www.catapult-ventures.com/site/assets/files/1356/blueberry_kn-biog-picture.jpg?9cu2 https://www.catapult-ventures.com/news/cytox-mednous-coverage-genetic-risk-assessment-in-alzheimers-disease/ 2023-05-03T21:57:27+01:00 https://www.catapult-ventures.com/site/assets/files/1347/cytox_logo.jpeg?9ctx https://www.catapult-ventures.com/news/rinicare-receives-funding-support-from-innovate-uk/ 2023-05-03T21:57:28+01:00 https://www.catapult-ventures.com/site/assets/files/1348/rinicare_logo.png?9cty https://www.catapult-ventures.com/news/catapult-invests-in-biohabit-through-the-gm-c-life-sciences-fund/ 2023-05-03T21:57:28+01:00 https://www.catapult-ventures.com/site/assets/files/1349/biohabit_logo.jpg?9cty https://www.catapult-ventures.com/news/blueberry-therapeutics-receives-clearance-from-the-fda-to-proceed-with-the-clinical-investigation-of-bb2603/ 2023-05-03T21:57:28+01:00 https://www.catapult-ventures.com/site/assets/files/1350/blueberry_therapeutics_logo_rgb.jpg?9cty https://www.catapult-ventures.com/news/blueberry-therapeutics-appoints-dr-adrian-howd-to-board-of-directors/ 2023-05-03T21:57:28+01:00 https://www.catapult-ventures.com/site/assets/files/1351/blueberry_therapeutics_logo_rgb.jpg?9cty https://www.catapult-ventures.com/news/oxford-biotherapeutics-initiates-dose-escalation-portion-of-u.s-phase-i-clinical-trial-for-obt076-in-patients-with-ad/ 2023-05-03T21:57:24+01:00 https://www.catapult-ventures.com/site/assets/files/1342/897_obt-rgb_500_192.jpg?9ctu https://www.catapult-ventures.com/news/cytox-appoints-ian-gilham-as-new-chairman-of-the-board/ 2023-05-03T21:57:24+01:00 https://www.catapult-ventures.com/site/assets/files/1343/cytox_logo.jpeg?9ctu https://www.catapult-ventures.com/news/uki2s-catapult-ventures-and-jonathan-milner-invest-500k-in-gene-modulation-newcomer-pencil-biosciences/ 2023-05-03T21:57:24+01:00 https://www.catapult-ventures.com/site/assets/files/1344/pencil_bio_400dpilogo.jpg?9ctu https://www.catapult-ventures.com/news/amrc-dr-peter-jackson-article-in-laboratory-news/ 2023-05-03T21:57:24+01:00 https://www.catapult-ventures.com/site/assets/files/1345/amrcentre_logo_white.jpg?9ctu https://www.catapult-ventures.com/news/amr-centre-world-antibiotic-awareness-week/ 2023-05-03T21:57:24+01:00 https://www.catapult-ventures.com/site/assets/files/1346/amrcentre_logo_white.jpg?9ctu https://www.catapult-ventures.com/news/amr-centre-candidate-targets-superbugs-with-problem-metallo-lactamase-enzymes/ 2023-05-03T21:57:20+01:00 https://www.catapult-ventures.com/site/assets/files/1337/amrc_mbl_nov_2019.jpg?9ctq https://www.catapult-ventures.com/news/nexus-labs-selected-for-prestigious-accelerator-programme-at-alderley-park/ 2023-05-03T21:57:20+01:00 https://www.catapult-ventures.com/site/assets/files/1338/nexus_labs_cropped.jpg?9ctq https://www.catapult-ventures.com/news/maxwellias-anna-maxwell-nominated-for-top-50-movers-shakers-in-biobusiness-2019/ 2023-05-03T21:57:20+01:00 https://www.catapult-ventures.com/news/biorelate-launches-ai-powered-curation-engine-galactic-to-combat-the-growing-challenge-of-information-overload-in-bi/ 2023-05-03T21:57:20+01:00 https://www.catapult-ventures.com/site/assets/files/1340/biorelate.jpg?9ctq https://www.catapult-ventures.com/news/gendius-selected-for-pitch-palace-12.0/ 2023-05-03T21:57:21+01:00 https://www.catapult-ventures.com/site/assets/files/1341/gendiuys_2019-oct-pitchatpalace12.jpg?9ctr https://www.catapult-ventures.com/news/patient-feedback-suggests-that-smart-pill-bottle-could-help-improve-adherence-to-critical-medications/ 2023-05-03T21:57:16+01:00 https://www.catapult-ventures.com/site/assets/files/1332/elucid-mhealth_lifestyle-32.jpg?9ctm https://www.catapult-ventures.com/news/2019-biocap-call-for-pitches-competition-winner-announced/ 2023-05-03T21:57:16+01:00 https://www.catapult-ventures.com/site/assets/files/1333/biocap_2019_winner.jpg?9ctm https://www.catapult-ventures.com/news/sight-and-sound-technology-meet-with-microsoft-ceo/ 2023-05-03T21:57:16+01:00 https://www.catapult-ventures.com/site/assets/files/1334/sight_and_sound_microsoft.jpg?9ctm https://www.catapult-ventures.com/news/could-smart-pill-bottles-dispense-a-solution-to-drug-non-adherence/ 2023-05-03T21:57:17+01:00 https://www.catapult-ventures.com/site/assets/files/1335/elucid-mhealth_lifestyle-32.jpg?9ctn https://www.catapult-ventures.com/news/ai-driven-growth-sat-nav-for-diabetes-gendius-has-huge-ambitions-after-500k-fundraise/ 2023-05-03T21:57:17+01:00 https://www.catapult-ventures.com/site/assets/files/1336/gendius_logo.jpg?9ctn https://www.catapult-ventures.com/news/elucid-gets-us-patents-for-smart-pill-dispenser-device/ 2023-05-03T21:57:12+01:00 https://www.catapult-ventures.com/site/assets/files/1327/elucid-mhealth_lifestyle-32.jpg?9cti https://www.catapult-ventures.com/news/up-ventures-and-novartis-announce-cohort-for-greater-manchester-future-of-health-challenge/ 2023-05-03T21:57:12+01:00 https://www.catapult-ventures.com/site/assets/files/1328/gendius_logo.jpg?9cti https://www.catapult-ventures.com/news/rinicare-announces-appointment-of-new-chairman/ 2023-05-03T21:57:12+01:00 https://www.catapult-ventures.com/site/assets/files/1329/rinicare_logo.png?9cti https://www.catapult-ventures.com/news/rinicare-safe-ground-breaking-uhmbt-research-study-has-potential-to-transform-care-on-hospital-wards-across-uk/ 2023-05-03T21:57:12+01:00 https://www.catapult-ventures.com/site/assets/files/1330/rinicare_safe_mobile_alarm.png?9cti https://www.catapult-ventures.com/news/the-smart-pill-pot-tells-you-and-your-doctor-if-you-miss-a-dose/ 2023-05-03T21:57:13+01:00 https://www.catapult-ventures.com/site/assets/files/1331/elucid-mhealth_lifestyle-32.jpg?9ctj https://www.catapult-ventures.com/news/dementia-testing-specialist-boosted-with-six-figure-investment/ 2023-05-03T21:57:08+01:00 https://www.catapult-ventures.com/site/assets/files/1322/cytox_logo.jpeg?9cte https://www.catapult-ventures.com/news/the-amr-centre-set-for-partnership-with-shionogi-for-new-superbug-therapy/ 2023-05-03T21:57:08+01:00 https://www.catapult-ventures.com/site/assets/files/1323/dr_pete_jackson_executive_director_amr_centre.jpg?9cte https://www.catapult-ventures.com/news/university-and-healthtech-firm-elucid-mhealth-collaborate-to-develop-smart-pill-dispenser/ 2023-05-03T21:57:08+01:00 https://www.catapult-ventures.com/site/assets/files/1324/elucid_image_080719.jpg?9cte https://www.catapult-ventures.com/news/oxford-biotherapeutics-announces-receipt-of-a-milestone-payment-as-boehringer-ingelheim-advances-an-oncology-drug-cand/ 2023-05-03T21:57:08+01:00 https://www.catapult-ventures.com/site/assets/files/1325/obt_logo.png?9cte https://www.catapult-ventures.com/news/new-hope-for-port-wine-stain-patients-from-a-novel-image-guided-treatment/ 2023-05-03T21:57:08+01:00 https://www.catapult-ventures.com/site/assets/files/1326/michelson_person-with-disfiguring-port-wi.jpeg?9cte https://www.catapult-ventures.com/news/clin-e-cal-rafi-tone-app-shows-important-benefits-in-salford-study/ 2023-05-03T21:57:04+01:00 https://www.catapult-ventures.com/site/assets/files/1317/clin-e-cal_rafitone_game.jpg?9cta https://www.catapult-ventures.com/news/elucid-mhealth-launches-smart-pill-bottle-to-monitor-patient-adherence/ 2023-05-03T21:57:04+01:00 https://www.catapult-ventures.com/site/assets/files/1318/elucid-mhealth_lifestyle-32.jpg?9cta https://www.catapult-ventures.com/news/biorelate-appoints-kevin-cox-as-chairman-to-support-its-rapid-expansion-plans/ 2023-05-03T21:57:04+01:00 https://www.catapult-ventures.com/site/assets/files/1319/biorelate_kevin-cox.jpg?9cta https://www.catapult-ventures.com/news/nexus-labs-announces-launch-of-surgical-teaching/ 2023-05-03T21:57:04+01:00 https://www.catapult-ventures.com/site/assets/files/1320/nexus_labs_cropped.jpg?9cta https://www.catapult-ventures.com/news/catapult-exits-r2c-online/ 2023-05-03T21:57:04+01:00 https://www.catapult-ventures.com/site/assets/files/1321/r2c.png?9cta https://www.catapult-ventures.com/news/the-amr-centre-secures-2.3m-funding-boost/ 2023-05-03T21:56:58+01:00 https://www.catapult-ventures.com/site/assets/files/1312/amrcentre_logo_white.jpg?9ct4 https://www.catapult-ventures.com/news/biofilm-announces-new-brand-be/ 2023-05-03T21:56:58+01:00 https://www.catapult-ventures.com/site/assets/files/1313/biofilm.jpg?9ct4 https://www.catapult-ventures.com/news/rinicare-announces-prime-product-launch/ 2023-05-03T21:56:58+01:00 https://www.catapult-ventures.com/site/assets/files/1314/rinicare_prime.jpg?9ct4 https://www.catapult-ventures.com/news/uk-ai-companies-biorelate-and-intellegens-win-share-of-20m-in-innovate-uk-grant-competition-to-explore-creation-of-a/ 2023-05-03T21:56:59+01:00 https://www.catapult-ventures.com/site/assets/files/1315/biorelate.jpg?9ct5 https://www.catapult-ventures.com/news/nexus-labs-welcomes-new-senior-clinical-editor/ 2023-05-03T21:56:59+01:00 https://www.catapult-ventures.com/site/assets/files/1316/nexus_appointment.jpg?9ct5 https://www.catapult-ventures.com/news/yospace-sale-to-rtl-to-generate-an-expected-6.7x-return-for-catapult-ventures/ 2023-05-03T21:56:53+01:00 https://www.catapult-ventures.com/site/assets/files/1307/yospace_pink.png?9csz https://www.catapult-ventures.com/news/apex-molecular-plans-expansion-following-rebrand/ 2023-05-03T21:56:54+01:00 https://www.catapult-ventures.com/site/assets/files/1308/the-apex-molecular-team.jpg?9ct0 https://www.catapult-ventures.com/news/amr-centre-hails-government-action-plan-as-critical-step-in-tackling-antibiotic-crisis/ 2023-05-03T21:56:54+01:00 https://www.catapult-ventures.com/site/assets/files/1309/amrcentre_logo_white.jpg?9ct0 https://www.catapult-ventures.com/news/gendius-announces-launch-of-intellin/ 2023-05-03T21:56:54+01:00 https://www.catapult-ventures.com/site/assets/files/1310/intellin-applaunch.png?9ct0 https://www.catapult-ventures.com/news/peter-hamer-joins-surgacoll-as-chief-executive-officer/ 2023-05-03T21:56:54+01:00 https://www.catapult-ventures.com/site/assets/files/1311/surgacoll_fullcol_logosmall.jpg?9ct0 https://www.catapult-ventures.com/news/maxwellia-expand-their-team-with-two-new-appointments/ 2023-05-03T21:56:50+01:00 https://www.catapult-ventures.com/news/oxford-biotherapeutics-expands-strategic-collaboration-with-wuxi-biologics/ 2023-05-03T21:56:50+01:00 https://www.catapult-ventures.com/site/assets/files/1303/obt_logo.png?9csw https://www.catapult-ventures.com/news/med-tech-companies-triumph-at-the-bionow-awards/ 2023-05-03T21:56:50+01:00 https://www.catapult-ventures.com/site/assets/files/1304/2018_bionow_award_winners_1.jpg?9csw https://www.catapult-ventures.com/news/blueberry-therapeutics-announce-positive-results-from-a-phase-i-ii-clinical-trial/ 2023-05-03T21:56:50+01:00 https://www.catapult-ventures.com/site/assets/files/1305/blueberry_therapeutics_logo_rgb.jpg?9csw https://www.catapult-ventures.com/news/biofilm-seals-2.5m-funding-injection/ 2023-05-03T21:56:50+01:00 https://www.catapult-ventures.com/site/assets/files/1306/biofilm.jpg?9csw https://www.catapult-ventures.com/news/r2c-online-wins-at-2018-commercial-motor-awards/ 2023-05-03T21:56:46+01:00 https://www.catapult-ventures.com/site/assets/files/1297/2018_winners_group_shot.jpg?9css https://www.catapult-ventures.com/news/yprotech-receives-400k-funding-boost/ 2023-05-03T21:56:46+01:00 https://www.catapult-ventures.com/site/assets/files/1298/yprotech_completion.jpg?9css https://www.catapult-ventures.com/news/umi3-ltd-showcases-innovations-to-catapult-ventures/ 2023-05-03T21:56:46+01:00 https://www.catapult-ventures.com/site/assets/files/1299/winner.jpg?9css https://www.catapult-ventures.com/news/clin-e-cal-announces-investment-from-catapult-ventures-to-advance-its-pipeline-of-innovative-digital-health-respirator/ 2023-05-03T21:56:46+01:00 https://www.catapult-ventures.com/site/assets/files/1300/clin-e-cal_rafitone_game.jpg?9css https://www.catapult-ventures.com/news/yospace-provides-ibc-award-winning-solution-for-medialaan/ 2023-05-03T21:56:47+01:00 https://www.catapult-ventures.com/site/assets/files/1301/yospace_award.jpg?9cst https://www.catapult-ventures.com/news/cytox-expands-collaboration-with-aibl-to-identify-those-most-at-risk-to-rapidly-progress-to-alzheimers/ 2023-05-03T21:56:42+01:00 https://www.catapult-ventures.com/site/assets/files/1292/cytox_logo.jpeg?9cso https://www.catapult-ventures.com/news/npif-maven-equity-finance-and-catapult-ventures-alongside-new-manchester-tech-trust-angel-group-invest-700-000-i/ 2023-05-03T21:56:42+01:00 https://www.catapult-ventures.com/site/assets/files/1293/maven_biorelate-005.jpg?9cso https://www.catapult-ventures.com/news/gm-c-life-sciences-fund-announces-25th-investment/ 2023-05-03T21:56:42+01:00 https://www.catapult-ventures.com/site/assets/files/1294/msp_launch_photo.jpg?9cso https://www.catapult-ventures.com/news/yospace-spotx-and-kaltura-come-together-on-advanced-advertising/ 2023-05-03T21:56:43+01:00 https://www.catapult-ventures.com/site/assets/files/1295/kaltura_7sep2018.jpg?9csp https://www.catapult-ventures.com/news/catapult-exits-stagecoach/ 2023-05-03T21:56:43+01:00 https://www.catapult-ventures.com/site/assets/files/1296/stagecoach.png?9csp https://www.catapult-ventures.com/news/clyz-labs-announces-seed-funding-from-catapult-ventures-to-develop-cancertain-test-for-personalised-cancer-treatmen/ 2023-05-03T21:56:38+01:00 https://www.catapult-ventures.com/site/assets/files/1287/clyz_pr1.jpg?9csk https://www.catapult-ventures.com/news/blueberry-therapeutics-limited-closes-10m-funding-to-support-development-of-nanomedicines-portfolio/ 2023-05-03T21:56:38+01:00 https://www.catapult-ventures.com/site/assets/files/1288/1-blueberry-therapeutics-john-ridden-ceo.jpg?9csk https://www.catapult-ventures.com/news/nexus-labs-announces-seed-funding-from-catapult-ventures-and-biocity-to-launch-surgicalteaching.com/ 2023-05-03T21:56:39+01:00 https://www.catapult-ventures.com/site/assets/files/1289/nexus_labs_completion_photo.jpg?9csl https://www.catapult-ventures.com/news/abzena-signs-protein-engineering-agreement-with-nyu-langone-health/ 2023-05-03T21:56:39+01:00 https://www.catapult-ventures.com/site/assets/files/1290/abzena_logo_rgb72dpi.jpg?9csl https://www.catapult-ventures.com/news/innovate-uk-announces-precision-medicines-innovation-fund/ 2023-05-03T21:56:39+01:00 https://www.catapult-ventures.com/site/assets/files/1291/govuk-logo.jpg?9csl https://www.catapult-ventures.com/news/abzena-and-telix-sign-strategic-manufacturing-and-bioconjugation-agreement/ 2023-05-03T21:56:34+01:00 https://www.catapult-ventures.com/site/assets/files/1282/abzena_logo_rgb72dpi.jpg?9csg https://www.catapult-ventures.com/news/surgacoll-partners-with-sparta-to-deliver-high-quality-tissue-regeneration-products-improve-accessibility-and-time-to/ 2023-05-03T21:56:34+01:00 https://www.catapult-ventures.com/site/assets/files/1283/surgacoll_fullcol_logosmall.jpg?9csg https://www.catapult-ventures.com/news/acquisition-of-bwb-by-caf-group-wins-east-midlands-deal-of-the-year/ 2023-05-03T21:56:34+01:00 https://www.catapult-ventures.com/site/assets/files/1284/bwb_deal_of_the_year.jpg?9csg https://www.catapult-ventures.com/news/cytox-launches-collaboration-agreement-with-mayo-clinic-to-evaluate-novel-genetic-based-approaches-for-assessing-alzhe/ 2023-05-03T21:56:34+01:00 https://www.catapult-ventures.com/site/assets/files/1285/cytox_ad-neurone-806x393.jpg?9csg https://www.catapult-ventures.com/news/new-early-warning-device-to-detect-infection-in-dialysis-patients-completes-successful-clinical-pilot-in-manchester/ 2023-05-03T21:56:34+01:00 https://www.catapult-ventures.com/site/assets/files/1286/microbiosensor_nostrap_cmyk.jpg?9csg https://www.catapult-ventures.com/news/cytox-in-collaboration-with-akesogen-extends-genetic-test-for-assessing-alzheimers-risk-to-include-saliva-samples/ 2023-05-03T21:56:29+01:00 https://www.catapult-ventures.com/site/assets/files/1277/cytox_logo.jpeg?9csb https://www.catapult-ventures.com/news/maxwellia-announces-funding-to-accelerate-its-mission-for-self-care/ 2023-05-03T21:56:30+01:00 https://www.catapult-ventures.com/site/assets/files/1278/maxwellia_completion_photo.jpg?9csc https://www.catapult-ventures.com/news/yospace-to-showcase-the-worlds-most-advanced-server-side-ad-insertion-technology-at-nab-show/ 2023-05-03T21:56:30+01:00 https://www.catapult-ventures.com/site/assets/files/1279/yospace_pink.png?9csc https://www.catapult-ventures.com/news/renephra-secures-investment-from-deepbridge-capital-and-catapult-ventures/ 2023-05-03T21:56:30+01:00 https://www.catapult-ventures.com/site/assets/files/1280/renephra_completion_photo.jpeg?9csc https://www.catapult-ventures.com/news/abzena-strengthens-specialized-bioassay-offering-through-access-agreement-with-major-cell-line-depository/ 2023-05-03T21:56:30+01:00 https://www.catapult-ventures.com/site/assets/files/1281/abzena_logo_rgb72dpi.jpg?9csc https://www.catapult-ventures.com/news/cytox-awarded-new-innovate-uk-funding-for-alzheimers-disease-testing/ 2023-05-03T21:56:24+01:00 https://www.catapult-ventures.com/site/assets/files/1272/cytox_logo.jpeg?9cs6 https://www.catapult-ventures.com/news/oxford-biotherapeutics-appoints-chief-medical-officer-abderrahim-fandi-m.d-ph.d/ 2023-05-03T21:56:24+01:00 https://www.catapult-ventures.com/site/assets/files/1273/oxford_20biotherapeutics_201.jpg?9cs6 https://www.catapult-ventures.com/news/r2c-online-connects-over-50-000-fleet-and-workshop-users/ 2023-05-03T21:56:24+01:00 https://www.catapult-ventures.com/site/assets/files/1274/r2c.png?9cs6 https://www.catapult-ventures.com/news/r2c-software-saves-allan-morris-transport-100-000/ 2023-05-03T21:56:25+01:00 https://www.catapult-ventures.com/site/assets/files/1275/r2c.png?9cs7 https://www.catapult-ventures.com/news/manchester-imaging-raises-600k-to-launch-dental-diagnostic-software/ 2023-05-03T21:56:25+01:00 https://www.catapult-ventures.com/site/assets/files/1276/manchester-imaging_completion_photo.jpg?9cs7 https://www.catapult-ventures.com/news/australia-receives-first-two-revolutionary-skin-cancer-diagnostic-machines-from-vivosight/ 2023-05-03T21:56:13+01:00 https://www.catapult-ventures.com/site/assets/files/1267/michelson2.jpg?9crv https://www.catapult-ventures.com/news/acea-health-announces-funding-from-catapult-ventures-and-public-to-launch-innovative-digital-dental-and-medical-consen/ 2023-05-03T21:56:13+01:00 https://www.catapult-ventures.com/site/assets/files/1268/acea_flynotes.jpg?9crv https://www.catapult-ventures.com/news/yospace-and-nexplayer-announce-integration/ 2023-05-03T21:56:13+01:00 https://www.catapult-ventures.com/site/assets/files/1269/yospace_pink.png?9crv https://www.catapult-ventures.com/news/e-therapeutics-to-collaborate-with-intellegens-and-biorelate-to-enhance-and-extend-its-ai-technology-capabilities/ 2023-05-03T21:56:13+01:00 https://www.catapult-ventures.com/site/assets/files/1270/biorelate.jpg?9crv https://www.catapult-ventures.com/news/surgacoll-holdings-ltd-announces-series-a-funding-opens-hq-in-alderley-park/ 2023-05-03T21:56:14+01:00 https://www.catapult-ventures.com/site/assets/files/1271/surgacoll_fullcol_logosmall.jpg?9crw https://www.catapult-ventures.com/news/abzena-wins-5m-plus-deal-with-us-biotech-client/ 2023-05-03T21:55:45+01:00 https://www.catapult-ventures.com/site/assets/files/1262/abzena_logo_rgb72dpi.jpg?9cr3 https://www.catapult-ventures.com/news/biofilm-appoints-new-chief-executive/ 2023-05-03T21:55:45+01:00 https://www.catapult-ventures.com/site/assets/files/1263/biofilm_ian-stevens-ceo-1.jpg?9cr3 https://www.catapult-ventures.com/news/microbiosensor-named-investment-deal-of-the-year-at-bionow-awards/ 2023-05-03T21:55:45+01:00 https://www.catapult-ventures.com/site/assets/files/1264/microbiosensor_bionow_award_photo.jpg?9cr3 https://www.catapult-ventures.com/news/metalinear-ltd-secures-255k-seed-investment-for-targeted-antibacterial-research/ 2023-05-03T21:55:46+01:00 https://www.catapult-ventures.com/site/assets/files/1265/metalinear_completion_photo.jpg?9cr4 https://www.catapult-ventures.com/news/win-for-r2c-online-at-the-commercial-motor-awards-2017/ 2023-05-03T21:55:46+01:00 https://www.catapult-ventures.com/site/assets/files/1266/r2c.png?9cr4 https://www.catapult-ventures.com/news/catapult-ventures-appoints-chris-spencer-as-venture-partner/ 2023-05-03T21:55:41+01:00 https://www.catapult-ventures.com/site/assets/files/1257/chris_spencer_website.jpg?9cqz https://www.catapult-ventures.com/news/tv4-and-yospace-achieve-swedish-first-with-server-side-dynamic-ad-insertion-for-live-channels/ 2023-05-03T21:55:41+01:00 https://www.catapult-ventures.com/site/assets/files/1258/yospace_pink.png?9cqz https://www.catapult-ventures.com/news/sciton-announces-collaboration-with-michelson-diagnostics-to-develop-oct-image-guided-laser-applications/ 2023-05-03T21:55:41+01:00 https://www.catapult-ventures.com/site/assets/files/1259/michelson2.jpg?9cqz https://www.catapult-ventures.com/news/ergomeds-peprostat-successfully-completes-phase-ii-clinical-trial/ 2023-05-03T21:55:41+01:00 https://www.catapult-ventures.com/site/assets/files/1260/erogmed.png?9cqz https://www.catapult-ventures.com/news/arriva-bus-coach-reduce-admin-time-by-40-hours-per-week-with-r2c-online/ 2023-05-03T21:55:41+01:00 https://www.catapult-ventures.com/site/assets/files/1261/r2c.png?9cqz https://www.catapult-ventures.com/news/gendius-announces-funding-from-catapult-ventures-to-launch-innovative-digital-health-platform-for-patients-living-with/ 2023-05-03T21:55:35+01:00 https://www.catapult-ventures.com/site/assets/files/1252/catapult_gendius_pr_photo.jpg?9cqt https://www.catapult-ventures.com/news/ergomed-signs-first-commercialisation-deal-for-haemostatix-products/ 2023-05-03T21:55:35+01:00 https://www.catapult-ventures.com/site/assets/files/1253/erogmed.png?9cqt https://www.catapult-ventures.com/news/amr-centre-to-partner-with-us-biotech-company/ 2023-05-03T21:55:36+01:00 https://www.catapult-ventures.com/site/assets/files/1254/amrcentre_logo_white.jpg?9cqu https://www.catapult-ventures.com/news/medtech-company-secures-investment/ 2023-05-03T21:55:36+01:00 https://www.catapult-ventures.com/site/assets/files/1255/elucid.jpeg?9cqu https://www.catapult-ventures.com/news/new-opportunities-for-menarini-and-obt/ 2023-05-03T21:55:36+01:00 https://www.catapult-ventures.com/site/assets/files/1256/obt-rgb_500_192.jpg?9cqu https://www.catapult-ventures.com/news/videology-partners-with-yospace-for-addressable-tv/ 2023-05-03T21:55:30+01:00 https://www.catapult-ventures.com/site/assets/files/1247/yospace_pink.png?9cqo https://www.catapult-ventures.com/news/bitmovin-partners-with-yospace/ 2023-05-03T21:55:31+01:00 https://www.catapult-ventures.com/site/assets/files/1248/yospace_pink.png?9cqp https://www.catapult-ventures.com/news/ergomed-completes-phase-iib-study-recruitment-six-months-ahead-of-schedule-for-its-innovative-coagulant-peprostat/ 2023-05-03T21:55:31+01:00 https://www.catapult-ventures.com/site/assets/files/1249/erogmed.png?9cqp https://www.catapult-ventures.com/news/venson-signs-contract-with-r2c-online/ 2023-05-03T21:55:31+01:00 https://www.catapult-ventures.com/site/assets/files/1250/r2c.png?9cqp https://www.catapult-ventures.com/news/blueberry-to-progress-nanomedicine-platform-to-include-novel-acne-therapy/ 2023-05-03T21:55:31+01:00 https://www.catapult-ventures.com/site/assets/files/1251/blueberry_therapeutics_logo_rgb.jpg?9cqp https://www.catapult-ventures.com/news/catapult-portfolio-company-bwb-joins-caf-group/ 2023-05-03T21:55:25+01:00 https://www.catapult-ventures.com/site/assets/files/1242/bwbweb.png?9cqj https://www.catapult-ventures.com/news/abzena-and-obi-pharma-sign-thiobridge-licence-agreement/ 2023-05-03T21:55:25+01:00 https://www.catapult-ventures.com/site/assets/files/1243/abzena_logo_rgb72dpi.jpg?9cqj https://www.catapult-ventures.com/news/bt-sport-extends-yospace-dynamic-ad-insertion-deal/ 2023-05-03T21:55:25+01:00 https://www.catapult-ventures.com/site/assets/files/1244/yospace_pink.png?9cqj https://www.catapult-ventures.com/news/bwb-wins-technology-champion-award/ 2023-05-03T21:55:25+01:00 https://www.catapult-ventures.com/site/assets/files/1245/bwbweb.png?9cqj https://www.catapult-ventures.com/news/peprostat-phase-iib-study-passes-recruitment-mid-point-ahead-of-schedule-top-line-results-brought-forward-to-q4-20/ 2023-05-03T21:55:26+01:00 https://www.catapult-ventures.com/site/assets/files/1246/erogmed.png?9cqk https://www.catapult-ventures.com/news/auto-windscreens-joins-r2cs-digital-platform/ 2023-05-03T21:55:16+01:00 https://www.catapult-ventures.com/site/assets/files/1237/r2c.png?9cqa https://www.catapult-ventures.com/news/cytox-raises-2.6m-led-by-catapult-ventures-to-launch-predictive-test-for-alzheimers-disease/ 2023-05-03T21:55:17+01:00 https://www.catapult-ventures.com/site/assets/files/1238/cytox_completion_photo.jpg?9cqb https://www.catapult-ventures.com/news/oxford-biotherapeutics-appoints-senior-clinical-biotech-executive-as-non-executive-director/ 2023-05-03T21:55:17+01:00 https://www.catapult-ventures.com/site/assets/files/1239/oxford_20biotherapeutics_201.jpg?9cqb https://www.catapult-ventures.com/news/proveca-and-tanner-pharma-initiate-global-managed-access-program-for-sialanar/ 2023-05-03T21:55:17+01:00 https://www.catapult-ventures.com/site/assets/files/1240/proveca_logo.jpg?9cqb https://www.catapult-ventures.com/news/bioverativ-to-acquire-true-north-therapeutics-and-the-abzena-inside-portfolio-product-tnt009/ 2023-05-03T21:55:17+01:00 https://www.catapult-ventures.com/site/assets/files/1241/abzena_logo_rgb72dpi.jpg?9cqb https://www.catapult-ventures.com/news/proctors-transport-see-vast-savings-100-compliance-since-using-r2c-onlines-digital-driver-solution/ 2023-05-03T21:55:01+01:00 https://www.catapult-ventures.com/site/assets/files/1232/r2c.png?9cpv https://www.catapult-ventures.com/news/yospace-and-mtm-launch-the-linear-ip-video-forum-at-connected-tv-world-summit/ 2023-05-03T21:55:01+01:00 https://www.catapult-ventures.com/site/assets/files/1233/yospace_pink.png?9cpv https://www.catapult-ventures.com/news/abzena-to-pursue-12-million-investment-program-to-upgrade-and-expand-its-san-diego-biomanufacturing-operations/ 2023-05-03T21:55:01+01:00 https://www.catapult-ventures.com/site/assets/files/1234/abzena_logo_rgb72dpi.jpg?9cpv https://www.catapult-ventures.com/news/blueberry-therapeutics-commence-phase-i-ii-clinical-trial-of-lead-product-bb2603/ 2023-05-03T21:55:01+01:00 https://www.catapult-ventures.com/site/assets/files/1235/blueberry_therapeutics_logo_rgb.jpg?9cpv https://www.catapult-ventures.com/news/catapult-portfolio-company-hangar-seven-acquired-by-the-hut-group/ 2023-05-03T21:55:02+01:00 https://www.catapult-ventures.com/site/assets/files/1236/hangar7_new_logo.jpg?9cpw https://www.catapult-ventures.com/news/proveca-raises-4m-led-by-catapult-ventures-to-launch-childrens-drug-sialanar-in-europe-and-accelerate-children/ 2023-05-03T21:54:56+01:00 https://www.catapult-ventures.com/site/assets/files/1227/proveca_completion_photo.jpg?9cpq https://www.catapult-ventures.com/news/catapult-generates-3.5x-return-from-sale-of-monica-healthcare/ 2023-05-03T21:54:56+01:00 https://www.catapult-ventures.com/site/assets/files/1228/monica_patch.jpg?9cpq https://www.catapult-ventures.com/news/catapult-sells-silver-lining-solutions-to-us-based-genesys/ 2023-05-03T21:54:56+01:00 https://www.catapult-ventures.com/site/assets/files/1229/355_silverliningsolutions.jpg?9cpq https://www.catapult-ventures.com/news/bwb-ranked-no-59-in-the-sunday-times-best-100-companies/ 2023-05-03T21:54:57+01:00 https://www.catapult-ventures.com/site/assets/files/1230/bwbweb.png?9cpr https://www.catapult-ventures.com/news/edan-instruments-inc-is-the-new-distributor-for-monica-an24-in-china/ 2023-05-03T21:54:57+01:00 https://www.catapult-ventures.com/site/assets/files/1231/monica_20logo_20hi_20res.jpg?9cpr https://www.catapult-ventures.com/news/oxford-biotherapeutics-strengthens-board-of-directors-with-appointment-of-two-biotech-veterans/ 2023-05-03T21:54:51+01:00 https://www.catapult-ventures.com/site/assets/files/1222/oxford_20biotherapeutics_201.jpg?9cpl https://www.catapult-ventures.com/news/r2c-online-gears-transport-platform-for-growth/ 2023-05-03T21:54:52+01:00 https://www.catapult-ventures.com/site/assets/files/1223/r2c-online-tim-griffiths_popup.jpg?9cpm https://www.catapult-ventures.com/news/abzena-signs-new-thiobridge-license-agreement/ 2023-05-03T21:54:52+01:00 https://www.catapult-ventures.com/site/assets/files/1224/abzena_logo_rgb72dpi.jpg?9cpm https://www.catapult-ventures.com/news/whistl-posts-efficiency-benefits-with-r2c-online/ 2023-05-03T21:54:52+01:00 https://www.catapult-ventures.com/site/assets/files/1225/r2c.png?9cpm https://www.catapult-ventures.com/news/bwb-wins-major-national-award-for-staff-retention-strategy/ 2023-05-03T21:54:52+01:00 https://www.catapult-ventures.com/site/assets/files/1226/bwbweb.png?9cpm https://www.catapult-ventures.com/news/expansion-and-diversification-deliver-record-growth-for-bwb/ 2023-05-03T21:53:56+01:00 https://www.catapult-ventures.com/site/assets/files/1217/bwbweb.png?9co2 https://www.catapult-ventures.com/news/biofortuna-reaches-key-milestones-for-readyplex-blood-group-genotyping-product-family/ 2023-05-03T21:53:56+01:00 https://www.catapult-ventures.com/news/gm-c-life-sciences-fund-invests-in-yprotech-high-value-chemistry-services/ 2023-05-03T21:53:56+01:00 https://www.catapult-ventures.com/site/assets/files/1219/yprotech_completion.jpg?9co2 https://www.catapult-ventures.com/news/gm-c-life-sciences-fund-invests-in-swabtech/ 2023-05-03T21:53:57+01:00 https://www.catapult-ventures.com/site/assets/files/1220/swabtech_logo_final.jpg?9co3 https://www.catapult-ventures.com/news/catapult-ventures-seed-investments/ 2023-05-03T21:54:32+01:00 https://www.catapult-ventures.com/site/assets/files/1221/gmc_master_cropped_70pc.png?9co3 https://www.catapult-ventures.com/news/gm-c-life-sciences-fund-makes-further-seed-investments/ 2023-05-03T21:47:07+01:00 https://www.catapult-ventures.com/site/assets/files/1210/gmc_master_cropped_70pc.png?9ccp https://www.catapult-ventures.com/news/intamac-in-software-deal-with-sprue-aegis/ 2023-05-03T21:47:07+01:00 https://www.catapult-ventures.com/site/assets/files/1211/intamacweb.png?9ccp https://www.catapult-ventures.com/news/new-board-member-joins-monica/ 2023-05-03T21:47:07+01:00 https://www.catapult-ventures.com/site/assets/files/1212/wolfgang_b-w_square.png?9ccp https://www.catapult-ventures.com/news/catapult-ventures-appoints-dr-tony-flinn-as-venture-partner/ 2023-05-03T21:47:07+01:00 https://www.catapult-ventures.com/site/assets/files/1213/tony_flinn.jpg?9ccp https://www.catapult-ventures.com/news/faron-enters-into-an-agreement-with-abzena-for-the-manufacture-of-clevegen/ 2023-05-03T21:47:07+01:00 https://www.catapult-ventures.com/site/assets/files/1214/abzena_logo_rgb72dpi.jpg?9ccp https://www.catapult-ventures.com/news/monica-healthcare-is-a-winner-in-the-2016-premier-inc-innovation-celebrations/ 2023-05-03T21:46:42+01:00 https://www.catapult-ventures.com/site/assets/files/1205/monica_20logo_20hi_20res.jpg?9cc0 https://www.catapult-ventures.com/news/catapult-ventures-appoints-dr-david-whitcombe-as-venture-partner/ 2023-05-03T21:46:42+01:00 https://www.catapult-ventures.com/site/assets/files/1206/david_w_website.jpg?9cc0 https://www.catapult-ventures.com/news/probe-scientific-in-top-disruptive-medical-technologies-index/ 2023-05-03T21:46:43+01:00 https://www.catapult-ventures.com/site/assets/files/1207/probe_logo.jpg?9cc1 https://www.catapult-ventures.com/news/three-weeks-four-trophies-one-bwb/ 2023-05-03T21:46:43+01:00 https://www.catapult-ventures.com/site/assets/files/1208/bwbweb.png?9cc1 https://www.catapult-ventures.com/news/catapult-ventures-sells-haemostatix-to-ergomed/ 2023-05-03T21:46:43+01:00 https://www.catapult-ventures.com/site/assets/files/1209/haemostatix_20logo_20for_20website.jpg?9cc1 https://www.catapult-ventures.com/news/yospace-wins-at-mediatels-connected-consumer-awards/ 2023-05-03T21:46:33+01:00 https://www.catapult-ventures.com/site/assets/files/1200/yospace_pink.png?9cbr https://www.catapult-ventures.com/news/blueberry-therapeutics-raises-3m-led-by-gm-c-life-sciences-fund/ 2023-05-03T21:46:33+01:00 https://www.catapult-ventures.com/site/assets/files/1201/blueberry_therapeutics_logo_rgb.jpg?9cbr https://www.catapult-ventures.com/news/yospace-wins-newbay-medias-best-of-show-award-presented-by-tv-technology/ 2023-05-03T21:46:33+01:00 https://www.catapult-ventures.com/site/assets/files/1202/yospace_pink.png?9cbr https://www.catapult-ventures.com/news/catapult-exits-food-and-drug-analytical-services/ 2023-05-03T21:46:34+01:00 https://www.catapult-ventures.com/site/assets/files/1203/fdas_logo_cmyk_converted.jpg?9cbs https://www.catapult-ventures.com/news/oxford-biotherapeutics-licenses-nerviano-medical-sciences-drug-linker-technology-to-develop-novel-antibody-drug-conju/ 2023-05-03T21:46:34+01:00 https://www.catapult-ventures.com/site/assets/files/1204/oxford_20biotherapeutics_201.jpg?9cbs https://www.catapult-ventures.com/news/sky-media-to-use-yospaces-live-ad-insertion-solution-for-sky-go/ 2023-05-03T21:46:28+01:00 https://www.catapult-ventures.com/site/assets/files/1195/yospace_pink.png?9cbm https://www.catapult-ventures.com/news/abzena-issues-business-update-strong-second-half-momentum/ 2023-05-03T21:46:28+01:00 https://www.catapult-ventures.com/site/assets/files/1196/abzena_logo_rgb72dpi.jpg?9cbm https://www.catapult-ventures.com/news/gm-c-life-sciences-fund-announces-first-investments/ 2023-05-03T21:46:28+01:00 https://www.catapult-ventures.com/site/assets/files/1197/gmc_master_cropped_70pc.png?9cbm https://www.catapult-ventures.com/news/michelson-diagnostics-dynamic-oct-imaging-technology-reveals-changes-in-skin-blood-vessels-in-real-time/ 2023-05-03T21:46:28+01:00 https://www.catapult-ventures.com/site/assets/files/1198/michelson.jpg?9cbm https://www.catapult-ventures.com/news/abzena-announces-significant-licence-deal-for-thiobridge/ 2023-05-03T21:46:29+01:00 https://www.catapult-ventures.com/site/assets/files/1199/abzena_logo_rgb72dpi.jpg?9cbn https://www.catapult-ventures.com/news/catapult-secures-9x-cash-return-with-sale-of-accutronics/ 2023-05-03T21:46:14+01:00 https://www.catapult-ventures.com/site/assets/files/1191/accutronics_logo_final_300dpi_jpg.jpg?9cb8 https://www.catapult-ventures.com/news/catapult-ventures-appoints-dr-gareth-king-as-investment-manager/ 2023-05-03T21:46:14+01:00 https://www.catapult-ventures.com/site/assets/files/1192/gareth_website.jpg?9cb8 https://www.catapult-ventures.com/news/abzena-announces-antitope-consortium-receives-1.9m-european-grant/ 2023-05-03T21:46:15+01:00 https://www.catapult-ventures.com/site/assets/files/1193/abzena_logo_rgb72dpi.jpg?9cb9 https://www.catapult-ventures.com/news/philips-and-monica-healthcare-announce-collaboration-for-innovative-fetal-monitoring-solution/ 2023-05-03T21:46:15+01:00 https://www.catapult-ventures.com/site/assets/files/1194/monica_20logo_20hi_20res.jpg?9cb9 https://www.catapult-ventures.com/news/abzena-raises-20m-and-announces-acquisition/ 2023-05-03T23:31:02+01:00 https://www.catapult-ventures.com/site/assets/files/1517/abzena_logo_rgb72dpi.jpg?9h5w https://www.catapult-ventures.com/news/catapult-secures-exit-from-systems-integration-through-management-buy-out/ 2023-05-03T23:31:02+01:00 https://www.catapult-ventures.com/site/assets/files/1518/system_integration_logo.jpg?9h5w https://www.catapult-ventures.com/news/catapult-secures-5.2x-cash-return-after-successful-exit-from-oxford-cryosystems-through-management-buy-out/ 2023-05-03T23:31:02+01:00 https://www.catapult-ventures.com/site/assets/files/1519/oxcryologocolour.jpg?9h5w https://www.catapult-ventures.com/news/45m-life-sciences-fund-launched-at-alderley-park/ 2023-05-03T23:31:02+01:00 https://www.catapult-ventures.com/site/assets/files/1520/msp_launch_photo.jpg?9h5w https://www.catapult-ventures.com/news/catapult-ventures-announces-the-acquisition-of-lumora-by-erba-diagnostics-mannheim/ 2023-05-03T23:31:02+01:00 https://www.catapult-ventures.com/site/assets/files/1521/lumora_logo_with_slogan.jpg?9h5w https://www.catapult-ventures.com/news/abzena-completes-pacificgmp-acquisition/ 2023-05-03T23:31:18+01:00 https://www.catapult-ventures.com/site/assets/files/1522/abzena_logo_rgb72dpi.jpg?9h6c https://www.catapult-ventures.com/news/lumora-sells-heat-elution-technology-to-roche/ 2023-05-03T23:31:18+01:00 https://www.catapult-ventures.com/site/assets/files/1523/lumora-final-logo-blend2.gif?9h6c https://www.catapult-ventures.com/news/bwb-completes-a-second-acquisition/ 2023-05-03T23:31:18+01:00 https://www.catapult-ventures.com/site/assets/files/1524/bwbweb.png?9h6c https://www.catapult-ventures.com/news/oxford-biotherapeutics-receives-10-million-capital-term-loan-from-silicon-valley-bank/ 2023-05-03T23:31:18+01:00 https://www.catapult-ventures.com/site/assets/files/1525/obt_logo_new.png?9h6c https://www.catapult-ventures.com/news/biofortuna-launches-its-new-approach-to-custom-ivd-manufacture-and-development-services/ 2023-05-03T23:31:18+01:00 https://www.catapult-ventures.com/news/silver-lining-solutions-makes-senior-appointment-to-lead-growth-in-the-americas/ 2023-05-03T23:31:22+01:00 https://www.catapult-ventures.com/site/assets/files/1527/355_silverliningsolutions.jpg?9h6g https://www.catapult-ventures.com/news/innovative-bwb-light-rail-project-shortlisted-in-competition/ 2023-05-03T23:31:22+01:00 https://www.catapult-ventures.com/site/assets/files/1528/bwbweb.png?9h6g https://www.catapult-ventures.com/news/r2c-online-deliver-tenfold-increase-in-productivity-for-bertschi-uk/ 2023-05-03T23:31:22+01:00 https://www.catapult-ventures.com/site/assets/files/1529/r2c.png?9h6g https://www.catapult-ventures.com/news/haemostatix-wins-healthcare-award-at-royal-society-of-chemistrys-emerging-technologies-showcase/ 2023-05-03T23:31:22+01:00 https://www.catapult-ventures.com/site/assets/files/1530/haemostatix_20logo_20for_20website.jpg?9h6g https://www.catapult-ventures.com/news/monica-healthcare-establishes-commercial-operations-in-the-usa/ 2023-05-03T23:31:22+01:00 https://www.catapult-ventures.com/site/assets/files/1531/monica_20logo_20hi_20res.jpg?9h6g https://www.catapult-ventures.com/news/bwb-sweeps-the-board-at-the-ace-awards/ 2023-05-03T23:31:25+01:00 https://www.catapult-ventures.com/site/assets/files/1532/bwbweb.png?9h6j https://www.catapult-ventures.com/news/abzena-says-gilead-advancing-antibody-to-further-clinical-trials/ 2023-05-03T23:31:25+01:00 https://www.catapult-ventures.com/site/assets/files/1533/abzena_logo_rgb72dpi.jpg?9h6j https://www.catapult-ventures.com/news/the-dark-side-nominated-for-bva-award/ 2023-05-03T23:31:26+01:00 https://www.catapult-ventures.com/site/assets/files/1534/hangar7_new_logo.jpg?9h6k https://www.catapult-ventures.com/news/michelson-diagnostics-launches-next-generation-oct-system-vivosight-dx/ 2023-05-03T23:31:26+01:00 https://www.catapult-ventures.com/site/assets/files/1535/michelson.jpg?9h6k https://www.catapult-ventures.com/news/two-partners-enter-clinical-development-with-biopharmaceuticals-enabled-by-abzenas-technology/ 2023-05-03T23:31:26+01:00 https://www.catapult-ventures.com/site/assets/files/1536/abzena_logo_rgb72dpi.jpg?9h6k https://www.catapult-ventures.com/news/mumbais-sion-hospital-takes-its-first-delivery-of-monicas-an24-foetal-monitoring-device/ 2023-05-03T23:31:29+01:00 https://www.catapult-ventures.com/site/assets/files/1537/monica_20logo_20hi_20res.jpg?9h6n https://www.catapult-ventures.com/news/lumora-named-as-company-to-watch-in-2015-by-leading-industry-publisher/ 2023-05-03T23:31:29+01:00 https://www.catapult-ventures.com/site/assets/files/1538/lumora-final-logo-blend2.gif?9h6n https://www.catapult-ventures.com/news/shortlist-hat-trick-for-bwb-at-the-ace-engineering-excellence-awards-2015/ 2023-05-03T23:31:29+01:00 https://www.catapult-ventures.com/site/assets/files/1539/bwbweb.png?9h6n https://www.catapult-ventures.com/news/bwb-part-of-the-team-delivering-one-of-londons-first-housing-zones-new-bermondsey/ 2023-05-03T23:31:29+01:00 https://www.catapult-ventures.com/site/assets/files/1540/bwbweb.png?9h6n https://www.catapult-ventures.com/news/new-vp-appointment-at-abzena/ 2023-05-03T23:31:29+01:00 https://www.catapult-ventures.com/site/assets/files/1541/abzena_logo_rgb72dpi.jpg?9h6n https://www.catapult-ventures.com/news/cyclops-and-thinkware-announce-innovative-content-partnership/ 2023-05-03T23:31:32+01:00 https://www.catapult-ventures.com/site/assets/files/1542/cyclops_1.jpg?9h6q https://www.catapult-ventures.com/news/biofortuna-appoints-new-chairman/ 2023-05-03T23:31:32+01:00 https://www.catapult-ventures.com/news/r2c-online-software-aids-compliance-for-leeds-commercial-vehicle-hire/ 2023-05-03T23:31:32+01:00 https://www.catapult-ventures.com/site/assets/files/1544/r2c.png?9h6q https://www.catapult-ventures.com/news/andy-hill-appointed-chief-executive-officer-at-michelson-diagnostics/ 2023-05-03T23:31:33+01:00 https://www.catapult-ventures.com/site/assets/files/1545/michelson.jpg?9h6r https://www.catapult-ventures.com/news/monica-healthcare-completes-new-2-million-investment-round/ 2023-05-03T23:31:33+01:00 https://www.catapult-ventures.com/site/assets/files/1546/monica_20logo_20hi_20res.jpg?9h6r https://www.catapult-ventures.com/news/biofortuna-ltd-closes-a-1.5m-funding-round/ 2023-05-03T23:31:35+01:00 https://www.catapult-ventures.com/news/oxford-biotherapeutics-grants-an-exclusive-license-to-boehringer-ingelheim/ 2023-05-03T23:31:35+01:00 https://www.catapult-ventures.com/site/assets/files/1548/obt_logo_new.png?9h6t https://www.catapult-ventures.com/news/antitope-inserm-and-baylor-institute-to-collaborate-to-produce-manufacturing-cell-lines-for-two-novel-vaccines-for-hi/ 2023-05-03T23:31:35+01:00 https://www.catapult-ventures.com/site/assets/files/1549/abzena_logo_rgb72dpi.jpg?9h6t https://www.catapult-ventures.com/news/comply-serve-wins-at-construction-computing-awards/ 2023-05-03T23:32:17+01:00 https://www.catapult-ventures.com/site/assets/files/1550/complyserve.jpg?9h7z https://www.catapult-ventures.com/news/obt-and-menarini-announce-start-of-first-in-human-clinical-study-to-treat-acute-myeloid-leukemia/ 2023-05-03T23:32:17+01:00 https://www.catapult-ventures.com/site/assets/files/1551/obt_logo_new.png?9h7z https://www.catapult-ventures.com/news/amanda-westwood-ceo-of-silver-lining-solutions-gives-small-business-tips-in-this-is-money-magazine/ 2023-05-03T23:32:17+01:00 https://www.catapult-ventures.com/site/assets/files/1552/355_silverliningsolutions.jpg?9h7z https://www.catapult-ventures.com/news/abzenas-ceo-dr-john-burt-talks-to-cambridge-business-about-the-companys-recent-floatation-on-aim-and-its-unusual-b/ 2023-05-03T23:32:17+01:00 https://www.catapult-ventures.com/site/assets/files/1553/abzena_logo_rgb72dpi.jpg?9h7z https://www.catapult-ventures.com/news/brandhouse-wins-top-industry-design-award/ 2023-05-03T23:32:17+01:00 https://www.catapult-ventures.com/site/assets/files/1554/squashd.jpg?9h7z https://www.catapult-ventures.com/news/hangar-seven-acquires-strategic-video-content-specialists-media-ark/ 2023-05-03T23:32:21+01:00 https://www.catapult-ventures.com/site/assets/files/1555/h7_20logo_20cool_20grey-black.jpg?9h83 https://www.catapult-ventures.com/news/michelson-diagnostics-launches-new-improved-version-of-vivosight-oct-scanner-with-micro-camera-to-aid-skin-cancer-diag/ 2023-05-03T23:32:22+01:00 https://www.catapult-ventures.com/site/assets/files/1556/michelson.jpg?9h84 https://www.catapult-ventures.com/news/new-middle-east-office-for-uk-rail-project-assurance-firm/ 2023-05-03T23:32:22+01:00 https://www.catapult-ventures.com/site/assets/files/1557/complyserve.jpg?9h84 https://www.catapult-ventures.com/news/obt-announces-second-clinical-development-candidate-from-its-1bn-oncology-investment-alliance/ 2023-05-03T23:32:22+01:00 https://www.catapult-ventures.com/site/assets/files/1558/obt_logo_new.png?9h84 https://www.catapult-ventures.com/news/intamac-continues-growth-with-appointment-of-new-coo-cto/ 2023-05-03T23:32:22+01:00 https://www.catapult-ventures.com/site/assets/files/1559/intamacweb.png?9h84 https://www.catapult-ventures.com/news/comply-serve-secures-further-funding/ 2023-05-03T23:32:25+01:00 https://www.catapult-ventures.com/site/assets/files/1560/complyserve.jpg?9h87 https://www.catapult-ventures.com/news/britvic-appoints-brandhouse-on-tango/ 2023-05-03T23:32:25+01:00 https://www.catapult-ventures.com/site/assets/files/1561/h7_20logo_20cool_20grey-black.jpg?9h87 https://www.catapult-ventures.com/news/abzenas-subsidiary-antitope-and-university-college-london-enter-into-research-licence-agreement/ 2023-05-03T23:32:25+01:00 https://www.catapult-ventures.com/site/assets/files/1562/abzena_logo_rgb72dpi.jpg?9h87 https://www.catapult-ventures.com/news/biofortuna-expands-freeze-dried-production-service/ 2023-05-03T23:32:25+01:00 https://www.catapult-ventures.com/news/oxford-biotherapeutics-appoints-eugen-leo-md-phd-mba-as-head-of-clinical-development/ 2023-05-03T23:32:26+01:00 https://www.catapult-ventures.com/site/assets/files/1564/obt_logo_new.png?9h88 https://www.catapult-ventures.com/news/abzena-raises-20-million-in-connection-with-forthcoming-admission-to-aim/ 2023-05-03T23:32:28+01:00 https://www.catapult-ventures.com/site/assets/files/1565/abzena_logo_rgb72dpi.jpg?9h8a https://www.catapult-ventures.com/news/oxford-biotherapeutics-appoints-dr-keith-e-wilson-as-chief-scientific-officer/ 2023-05-03T23:32:29+01:00 https://www.catapult-ventures.com/site/assets/files/1566/obt-rgb_500_192.jpg?9h8b https://www.catapult-ventures.com/news/new-class-of-coagulant-gets-go-ahead-for-clinical-trial/ 2023-05-03T23:32:29+01:00 https://www.catapult-ventures.com/site/assets/files/1567/haemostatix_20logo_20for_20website.jpg?9h8b https://www.catapult-ventures.com/news/polytherics-and-antitope-form-abzena/ 2023-05-03T23:32:29+01:00 https://www.catapult-ventures.com/site/assets/files/1568/abzena_logo_rgb72dpi.jpg?9h8b https://www.catapult-ventures.com/news/oxford-cryosystems-wins-export-award-category-at-made-in-england-awards-2014/ 2023-05-03T23:32:29+01:00 https://www.catapult-ventures.com/site/assets/files/1569/oxcryologocolour.jpg?9h8b https://www.catapult-ventures.com/news/oxford-biotherapeutics-secures-exclusive-global-rights-from-amgen-and-immunog/ 2023-05-03T23:32:32+01:00 https://www.catapult-ventures.com/site/assets/files/1570/obt-rgb_500_192.jpg?9h8e https://www.catapult-ventures.com/news/critical-pharmaceuticals-announces-us-patent-allowance/ 2023-05-03T23:32:32+01:00 https://www.catapult-ventures.com/site/assets/files/1571/critical_20pharmaceuticals_20colour_20logo.jpg?9h8e https://www.catapult-ventures.com/news/monica-healthcare-secures-ntech-grant/ 2023-05-03T23:32:32+01:00 https://www.catapult-ventures.com/site/assets/files/1572/monica_20logo_20hi_20res.jpg?9h8e https://www.catapult-ventures.com/news/oxford-cryosystems-helps-push-the-boundaries-of-the-known-universe/ 2023-05-03T23:32:32+01:00 https://www.catapult-ventures.com/site/assets/files/1573/oxcryologocolour.jpg?9h8e https://www.catapult-ventures.com/news/onwards-and-upwards-for-bwb-birmingham/ 2023-05-03T23:32:32+01:00 https://www.catapult-ventures.com/site/assets/files/1574/bwbweb.png?9h8e https://www.catapult-ventures.com/news/sprue-aegis-plc-sprue-and-intamac-to-launch-connected-safety-solution/ 2023-05-03T23:32:35+01:00 https://www.catapult-ventures.com/site/assets/files/1575/intamacweb.png?9h8h https://www.catapult-ventures.com/news/biofortuna-receives-fda-clearance-of-its-sspgo-line-of-hla-molecular-diagnostic-freeze-dried-kits/ 2023-05-03T23:32:35+01:00 https://www.catapult-ventures.com/news/new-england-biolabs-announces-supply-agreement-with-lumora/ 2023-05-03T23:32:35+01:00 https://www.catapult-ventures.com/site/assets/files/1577/lumora-final-logo-blend2.gif?9h8h https://www.catapult-ventures.com/news/prime-minister-david-cameron-visits-portfolio-company-oxford-cryosystems/ 2023-05-03T23:32:35+01:00 https://www.catapult-ventures.com/site/assets/files/1578/bcpdavidcameronvisit1005x.jpg?9h8h https://www.catapult-ventures.com/news/michelson-diagnostics-targets-malignant-melanoma-using-oct-imaging-with-2.3m-eu-funding/ 2023-05-03T23:32:36+01:00 https://www.catapult-ventures.com/site/assets/files/1579/michelson.jpg?9h8h https://www.catapult-ventures.com/news/michelson-diagnostics-announces-1.98-million-financing/ 2023-05-03T23:32:38+01:00 https://www.catapult-ventures.com/site/assets/files/1580/michelson.jpg?9h8k https://www.catapult-ventures.com/news/oxford-biotherapeutics-and-menarini-progress-enhanced-antibody-for-acute-myeloid-leukemia-in-1-billion-oncology-inves/ 2023-05-03T23:33:04+01:00 https://www.catapult-ventures.com/site/assets/files/1581/oxford_20biotherapeutics_201.jpg?9h9a https://www.catapult-ventures.com/news/zysis-receives-us-patent-for-long-acting-oral-aripiprazole-once-weekly/ 2023-05-03T23:33:04+01:00 https://www.catapult-ventures.com/site/assets/files/1582/45094_zysis-logo-print.gif?9h9a https://www.catapult-ventures.com/news/technology-strategy-board-awards-accutronics-100-000-for-medical-battery/ 2023-05-03T23:33:04+01:00 https://www.catapult-ventures.com/site/assets/files/1583/accutronics_logo_final_300dpi_jpg.jpg?9h9a https://www.catapult-ventures.com/news/patent-published-for-lumoras-novel-sample-preparation-technology/ 2023-05-03T23:33:04+01:00 https://www.catapult-ventures.com/site/assets/files/1584/lumora-final-logo-blend2.gif?9h9a https://www.catapult-ventures.com/news/polytherics-and-tube-pharma-collaborate-to-develop-novel-cytotoxic-payloads-for-antibody-drug-conjugates-adcs/ 2023-05-03T23:33:05+01:00 https://www.catapult-ventures.com/site/assets/files/1585/polytherics.jpg?9h9b https://www.catapult-ventures.com/news/innovative-new-blade-inspection-system-launched/ 2023-05-03T23:33:07+01:00 https://www.catapult-ventures.com/site/assets/files/1586/rts_20international_20only_20logo_20pantone.jpg?9h9d https://www.catapult-ventures.com/news/probe-scientific-signs-new-licensing-deal-with-menarini/ 2023-05-03T23:33:08+01:00 https://www.catapult-ventures.com/site/assets/files/1588/probe_microeye_photo2.jpg?9h9e https://www.catapult-ventures.com/news/zinwave-in-building-wireless-system-interfaces-with-managed-access-systems-deployed-by-the-military-and-correctional-i/ 2023-05-03T23:33:08+01:00 https://www.catapult-ventures.com/site/assets/files/1589/zinwave_logo_sm.jpg?9h9e https://www.catapult-ventures.com/news/catapult-makes-key-appointment/ 2023-05-03T23:33:08+01:00 https://www.catapult-ventures.com/site/assets/files/1590/jonathan_lowe_052a.jpg?9h9e https://www.catapult-ventures.com/news/biofortuna-raises-1.3m-of-investment-for-growth-in-its-freeze-dried-molecular-diagnostics-business-and-service-provi/ 2023-05-03T23:33:11+01:00 https://www.catapult-ventures.com/news/crystallon-instals-2000th-cryostream/ 2023-05-03T23:33:11+01:00 https://www.catapult-ventures.com/site/assets/files/1592/oxcryologocolour.jpg?9h9h https://www.catapult-ventures.com/news/polytherics-and-antitope-combine-to-create-leading-provider-of-solutions-to-enable-the-development-of-better-biopharma/ 2023-05-03T23:33:11+01:00 https://www.catapult-ventures.com/site/assets/files/1593/polytherics.jpg?9h9h https://www.catapult-ventures.com/news/sky-will-use-a-joint-nice-silver-lining-workforce-optimisation-solution-to-more-effectively-manage-its-multi-site-mul/ 2023-05-03T23:33:12+01:00 https://www.catapult-ventures.com/site/assets/files/1594/355_silverliningsolutions.jpg?9h9i https://www.catapult-ventures.com/news/lumora-signs-supply-agreement-with-promega-for-ultra-glo-luciferase-to-be-used-in-lumoras-bart-molecular-diagnosti/ 2023-05-03T23:33:12+01:00 https://www.catapult-ventures.com/site/assets/files/1595/lumora-final-logo-blend2.gif?9h9i https://www.catapult-ventures.com/news/sight-and-sound-celebrate-winning-the-midlands-venture-capital-backed-team-of-the-year-award-at-the-gala-dinner/ 2023-05-03T23:33:14+01:00 https://www.catapult-ventures.com/site/assets/files/1596/sight_and_sound_bvca.jpg?9h9k https://www.catapult-ventures.com/news/oxford-biotherapeutics-appoints-bryan-g-morton-as-chairman/ 2023-05-03T23:33:14+01:00 https://www.catapult-ventures.com/site/assets/files/1597/bryan_morton2bphoto.png?9h9k https://www.catapult-ventures.com/news/monica-healthcare-developing-new-generation-products/ 2023-05-03T23:33:14+01:00 https://www.catapult-ventures.com/site/assets/files/1598/monica_sm.jpg?9h9k https://www.catapult-ventures.com/news/michelson-diagnostics-wins-regulatory-approval-for-vivosight-oct-scanner-in-australia/ 2023-05-03T23:33:15+01:00 https://www.catapult-ventures.com/site/assets/files/1599/michelson.jpg?9h9l https://www.catapult-ventures.com/news/lumora-agrees-licence-and-development-program-for-veterinary-applications-with-biogal-galed-labs/ 2023-05-03T23:33:15+01:00 https://www.catapult-ventures.com/site/assets/files/1600/lumora-final-logo-blend2.gif?9h9l https://www.catapult-ventures.com/news/rts-gears-up-to-grab-larger-slice-of-renewable-energy-sector/ 2023-05-03T23:33:17+01:00 https://www.catapult-ventures.com/site/assets/files/1601/rts_20international_20only_20logo_20pantone.jpg?9h9n https://www.catapult-ventures.com/news/british-gas-leads-7m-investment-in-telecoms-and-data-centre-efficiency-company-4energy/ 2023-05-03T23:33:17+01:00 https://www.catapult-ventures.com/site/assets/files/1602/4-energylogo.jpg?9h9n https://www.catapult-ventures.com/news/catapult-makes-further-investment-into-kick-sport/ 2023-05-03T23:33:17+01:00 https://www.catapult-ventures.com/site/assets/files/1603/kick_20sport.jpg?9h9n https://www.catapult-ventures.com/news/probe-scientific-signs-a-non-exclusive-licence-with-menarini-diagnostics/ 2023-05-03T23:33:17+01:00 https://www.catapult-ventures.com/site/assets/files/1604/probe_logo.jpg?9h9n https://www.catapult-ventures.com/news/oxford-biotherapeutics-and-boehringer-ingelheim-enter-collaboration-to-discover-novel-antibody-targets-in-cancer/ 2023-05-03T23:33:18+01:00 https://www.catapult-ventures.com/site/assets/files/1605/oxford_20biotherapeutics_201.jpg?9h9o https://www.catapult-ventures.com/news/lumora-to-partner-with-find-to-develop-new-high-throughput-malaria-molecular-diagnostic-test-for-use-in-the-developin/ 2023-05-03T23:33:20+01:00 https://www.catapult-ventures.com/site/assets/files/1606/lumora-final-logo-blend2.gif?9h9q https://www.catapult-ventures.com/news/sight-and-sound-technology-win-bvca-award/ 2023-05-03T23:33:20+01:00 https://www.catapult-ventures.com/site/assets/files/1607/new_logo_full_colour.jpg?9h9q https://www.catapult-ventures.com/news/biofilm-shortlisted-for-bvca-awards/ 2023-05-03T23:33:21+01:00 https://www.catapult-ventures.com/site/assets/files/1608/biofilmlogo_20rgb.jpg?9h9r https://www.catapult-ventures.com/news/lumora-raises-700-000-to-accelerate-commercial-development/ 2023-05-03T23:33:21+01:00 https://www.catapult-ventures.com/site/assets/files/1609/lumora-final-logo-blend2.gif?9h9r https://www.catapult-ventures.com/news/catapult-announces-further-investment-in-nanotherics/ 2023-05-03T23:33:21+01:00 https://www.catapult-ventures.com/site/assets/files/1610/nanotherics_sm.jpg?9h9r https://www.catapult-ventures.com/news/portfolio-company-silver-lining-solutions-partners-with-nice-to-enhance-employee-performance-and-training/ 2023-05-03T23:33:23+01:00 https://www.catapult-ventures.com/site/assets/files/1611/355_silverliningsolutions.jpg?9h9t https://www.catapult-ventures.com/news/catapult-exits-whelan-refining/ 2023-05-03T23:33:23+01:00 https://www.catapult-ventures.com/site/assets/files/1612/john_whelan.jpg?9h9t https://www.catapult-ventures.com/news/sight-sound-technology-short-listed-for-bvca-awards/ 2023-05-03T23:33:24+01:00 https://www.catapult-ventures.com/site/assets/files/1613/new_logo_full_colour.jpg?9h9u https://www.catapult-ventures.com/news/bwb-builds-up-with-dks-consulting-deal/ 2023-05-03T23:33:24+01:00 https://www.catapult-ventures.com/site/assets/files/1614/98_bwblogo.jpg?9h9u https://www.catapult-ventures.com/news/accutronics-wins-award-for-innovation-in-products-and-processes-at-the-manufacturing-excellence-awards/ 2023-05-03T23:33:24+01:00 https://www.catapult-ventures.com/site/assets/files/1615/accutronics_logo_final_300dpi_jpg.jpg?9h9u https://www.catapult-ventures.com/news/oxford-biotherapeutics-sign-major-strategic-collaboration-with-menarini-group/ 2023-05-03T23:33:39+01:00 https://www.catapult-ventures.com/site/assets/files/1616/oxford_20biotherapeutics_201.jpg?9ha9 https://www.catapult-ventures.com/news/catapult-venture-managers-portfolio-company-haemostatix-receives-wellcome-trust-backing-to-take-lead-product-into-c/ 2023-05-03T23:33:40+01:00 https://www.catapult-ventures.com/site/assets/files/1617/haemostatix_20logo_20for_20website.jpg?9haa https://www.catapult-ventures.com/news/catapult-venture-managers-portfolio-company-hangar-seven-acquires-doco-london/ 2023-05-03T23:33:40+01:00 https://www.catapult-ventures.com/site/assets/files/1618/h7_20logo_20cool_20grey-black.jpg?9haa https://www.catapult-ventures.com/news/comply-serve-wins-banedanmark-signalling-project-contract/ 2023-05-03T23:33:40+01:00 https://www.catapult-ventures.com/site/assets/files/1619/172_complyserve_sm.jpg?9haa https://www.catapult-ventures.com/news/cyclops-telmap-announce-global-live-service-content-partnership/ 2023-05-03T23:33:40+01:00 https://www.catapult-ventures.com/site/assets/files/1620/cyclops_1.jpg?9haa https://www.catapult-ventures.com/news/michelson-diagnostics-appoints-xavier-yon-as-non-executive-director/ 2023-05-03T23:33:43+01:00 https://www.catapult-ventures.com/site/assets/files/1621/xavieryon-100px.png?9had https://www.catapult-ventures.com/news/catapult-secures-a-successful-exit-from-blackstar-amplification-through-secondary-sale-of-its-stake-to-foresight-group/ 2023-05-03T23:33:44+01:00 https://www.catapult-ventures.com/site/assets/files/1622/blackstar.jpg?9hae https://www.catapult-ventures.com/news/accutronics-wins-small-business-of-the-year-award/ 2023-05-03T23:33:44+01:00 https://www.catapult-ventures.com/site/assets/files/1623/accutronic_award_pic.png?9hae https://www.catapult-ventures.com/news/top-of-the-spotters-cyclops-speedwatch-wins-auto-express-recommended-award/ 2023-05-03T23:33:44+01:00 https://www.catapult-ventures.com/site/assets/files/1624/cyclops_speedwatch.png?9hae https://www.catapult-ventures.com/news/hangar-seven-takes-off-with-catapult-investment/ 2023-05-03T23:33:58+01:00 https://www.catapult-ventures.com/site/assets/files/1625/hangar_seven_tombstone_photo.jpg?9has https://www.catapult-ventures.com/news/catapult-deliver-knockout-investment-into-kick-sport/ 2023-05-03T23:33:59+01:00 https://www.catapult-ventures.com/site/assets/files/1626/cp150711_08.jpg?9hat https://www.catapult-ventures.com/news/catapult-mops-up-with-investment-into-acs/ 2023-05-03T23:33:59+01:00 https://www.catapult-ventures.com/site/assets/files/1627/acs_03.jpg?9hat https://www.catapult-ventures.com/news/lumora-attracts-second-stage-funding/ 2023-05-03T23:33:59+01:00 https://www.catapult-ventures.com/site/assets/files/1628/catapult_-_lumora_014.jpg?9hat https://www.catapult-ventures.com/news/catapult-and-mercia-invest-into-cutting-edge-intelligent-orthopaedics/ 2023-05-03T23:33:59+01:00 https://www.catapult-ventures.com/site/assets/files/1629/dsc_3256b.jpg?9hat https://www.catapult-ventures.com/news/monica-healthcare-gains-fda-clearance-for-groundbreaking-wireless-fetal-monitor/ 2023-05-03T23:34:03+01:00 https://www.catapult-ventures.com/site/assets/files/1630/monica_-_july_2007_004.jpg?9hax https://www.catapult-ventures.com/news/the-co-operative-and-catapult-finance-mbo-of-world-leading-oxford-cryosystems/ 2023-05-03T23:34:17+01:00 https://www.catapult-ventures.com/site/assets/files/1631/544oxford_20cryosystems.jpg?9hbb https://www.catapult-ventures.com/news/catapult-and-mercia-invest-in-staffordshire-based-nanotherics/ 2023-05-03T23:34:17+01:00 https://www.catapult-ventures.com/site/assets/files/1632/catapult_-_nanotherics_052.jpg?9hbb https://www.catapult-ventures.com/news/catapult-invests-in-mobile-video-delivery-technology/ 2023-05-03T23:34:17+01:00 https://www.catapult-ventures.com/site/assets/files/1633/yospace.jpg?9hbb https://www.catapult-ventures.com/news/catapult-invests-in-fast-growing-renewable-energy-sector/ 2023-05-03T23:34:17+01:00 https://www.catapult-ventures.com/site/assets/files/1634/catapult_rts_004.jpg?9hbb https://www.catapult-ventures.com/contact/ 2026-03-31T11:29:36+01:00 https://www.catapult-ventures.com/site/assets/files/1052/catapult_map.png?99nk